{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 245854, "items": [{"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T17:28:25Z", "timestamp": 1574184505426}, "reference-count": 0, "publisher": "Clarivate Analytics (US)", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drugs Today"], "published-print": {"date-parts": [[2006]]}, "DOI": "10.1358/dot.2006.42.1.957357", "type": "journal-article", "created": {"date-parts": [[2006, 3, 3]], "date-time": "2006-03-03T19:52:21Z", "timestamp": 1141415541000}, "page": "65", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Fabry disease"], "prefix": "10.1358", "volume": "42", "author": [{"given": "M.", "family": "Levin", "sequence": "first", "affiliation": []}], "member": "71", "container-title": ["Drugs of Today"], "language": "en", "deposited": {"date-parts": [[2007, 2, 13]], "date-time": "2007-02-13T20:56:13Z", "timestamp": 1171400173000}, "score": 29.899258, "issued": {"date-parts": [[2006]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2006]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1358/dot.2006.42.1.957357", "ISSN": ["1699-3993"], "issn-type": [{"value": "1699-3993", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T19:43:44Z", "timestamp": 1574451824840}, "publisher-location": "Dordrecht", "reference-count": 43, "publisher": "Springer Netherlands", "isbn-type": [{"value": "9789048190324", "type": "print"}, {"value": "9789048190331", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2010]]}, "DOI": "10.1007/978-90-481-9033-1_25", "type": "book-chapter", "created": {"date-parts": [[2010, 7, 31]], "date-time": "2010-07-31T18:26:49Z", "timestamp": 1280600809000}, "page": "389-399", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Agalsidase Alfa in the Treatment of Anderson-Fabry Disease"], "prefix": "10.1007", "author": [{"given": "Gregory M.", "family": "Pastores", "sequence": "first", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2010, 7, 10]]}, "reference": [{"issue": "6", "key": "25_CR1", "doi-asserted-by": "publisher", "first-page": "628", "DOI": "10.1097/MOP.0b013e3282f161f2", "volume": "19", "author": "TA Burrow", "year": "2007", "unstructured": "Burrow TA, Hopkin RJ, Leslie ND, Tinkle BT, Grabowski GA (2007) Enzyme reconstitution/replacement therapy for lysosomal storage diseases. Curr Opin Pediatr 19(6):628\u2013635", "journal-title": "Curr Opin Pediatr"}, {"issue": "1", "key": "25_CR2", "doi-asserted-by": "publisher", "first-page": "365", "DOI": "10.1073/pnas.97.1.365", "volume": "97", "author": "R Schiffmann", "year": "2000", "unstructured": "Schiffmann R, Murray GJ, Treco D et al (2000) Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease. Proc Natl Acad Sci USA 97(1):365\u2013370", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "21", "key": "25_CR3", "doi-asserted-by": "publisher", "first-page": "2743", "DOI": "10.1001/jama.285.21.2743", "volume": "285", "author": "R Schiffmann", "year": "2001", "unstructured": "Schiffmann R, Kopp JB, Austin HA III et al (2001) Enzyme replacement therapy in Fabry disease: a randomized controlled trial. J Am Med Assoc 285(21):2743\u20132749", "journal-title": "J Am Med Assoc"}, {"issue": "3", "key": "25_CR4", "doi-asserted-by": "publisher", "first-page": "236", "DOI": "10.1111/j.1365-2362.2004.01309.x", "volume": "34", "author": "A Mehta", "year": "2004", "unstructured": "Mehta A, Ricci R, Widmer U et al (2004) Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest 34(3):236\u2013242", "journal-title": "Eur J Clin Invest"}, {"issue": "8", "key": "25_CR5", "doi-asserted-by": "publisher", "first-page": "504", "DOI": "10.1097/GIM.0b013e318133fb1b", "volume": "9", "author": "JT Clarke", "year": "2007", "unstructured": "Clarke JT, West ML, Bultas J, Schiffmann R (2007) The pharmacology of multiple regimens of agalsidase alfa enzyme replacement therapy for Fabry disease. Genet Med 9(8):504\u2013509", "journal-title": "Genet Med"}, {"issue": "7", "key": "25_CR6", "doi-asserted-by": "publisher", "first-page": "617", "DOI": "10.1023/B:BOLI.0000005658.14563.77", "volume": "26", "author": "F Baehner", "year": "2003", "unstructured": "Baehner F, Kampmann C, Whybra C, Miebach E, Wiethoff CM, Beck M (2003) Enzyme replacement therapy in heterozygous females with Fabry disease results of a phase IIIB study. J Inherit Metab Dis 26(7):617\u2013627", "journal-title": "J Inherit Metab Dis"}, {"issue": "7", "key": "25_CR7", "doi-asserted-by": "publisher", "first-page": "1920", "DOI": "10.1093/ndt/gfm096", "volume": "22", "author": "GM Pastores", "year": "2007", "unstructured": "Pastores GM, Boyd E, Crandall K, Whelan A, Piersall L, Barnett N (2007) Safety and pharmacokinetics of agalsidase alfa in patients with Fabry disease and end-stage renal disease. Nephrol Dial Transplant 22(7):1920\u20131925", "journal-title": "Nephrol Dial Transplant"}, {"issue": "10", "key": "25_CR8", "doi-asserted-by": "publisher", "first-page": "1222", "DOI": "10.1177/0091270007305299", "volume": "47", "author": "M Ries", "year": "2007", "unstructured": "Ries M, Clarke JT, Whybra C et al (2007) Enzyme replacement in Fabry disease: pharmacokinetics and pharmacodynamics of agalsidase alpha in children and adolescents. J Clin Pharmacol 47(10):1222\u20131230", "journal-title": "J Clin Pharmacol"}, {"issue": "12", "key": "25_CR9", "doi-asserted-by": "publisher", "first-page": "838", "DOI": "10.1111/j.1365-2362.2004.01424.x", "volume": "34", "author": "M Beck", "year": "2004", "unstructured": "Beck M, Ricci R, Widmer U et al (2004) Fabry disease: overall effects of agalsidase alfa treatment. Eur J Clin Invest 34(12):838\u2013844", "journal-title": "Eur J Clin Invest"}, {"issue": "443", "key": "25_CR10", "first-page": "14", "volume": "92", "author": "F Dehout", "year": "2003", "unstructured": "Dehout F, Schwarting A, Beck M et al (2003) Effects of enzyme replacement therapy with agalsidase alfa on glomerular filtration rate in patients with Fabry disease: preliminary data. Acta Paediatr Suppl 92(443):14\u201315", "journal-title": "Acta Paediatr Suppl"}, {"issue": "2", "key": "25_CR11", "first-page": "77", "volume": "66", "author": "A Schwarting", "year": "2006", "unstructured": "Schwarting A, Dehout F, Feriozzi S et al (2006) Enzyme replacement therapy and renal function in 201 patients with Fabry disease. Clin Nephrol 66(2):77\u201384", "journal-title": "Clin Nephrol"}, {"issue": "5", "key": "25_CR12", "doi-asserted-by": "publisher", "first-page": "353", "DOI": "10.1159/000168482", "volume": "29", "author": "S Feriozzi", "year": "2009", "unstructured": "Feriozzi S, Schwarting A, Sunder-Plassmann G, West M, Cybulla M (2009) International Fabry Outcome Survey Investigators. Agalsidase alfa slows the decline in renal function in patients with Fabry disease. Am J Nephrol 29(5):353\u2013361", "journal-title": "Am J Nephrol"}, {"issue": "5", "key": "25_CR13", "doi-asserted-by": "publisher", "first-page": "1132", "DOI": "10.1681/ASN.2008080870", "volume": "20", "author": "M West", "year": "2009", "unstructured": "West M, Nicholls K, Mehta A et al (2009) Agalsidase alfa and kidney dysfunction in Fabry disease. J Am Soc Nephrol 20(5):1132\u20131139", "journal-title": "J Am Soc Nephrol"}, {"issue": "2", "key": "25_CR14", "doi-asserted-by": "publisher", "first-page": "153", "DOI": "10.1136/hrt.2006.104026", "volume": "94", "author": "DA Hughes", "year": "2008", "unstructured": "Hughes DA, Elliott PM, Shah J et al (2008) Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa. Heart 94(2):153\u2013158", "journal-title": "Heart"}, {"issue": "6", "key": "25_CR15", "doi-asserted-by": "publisher", "first-page": "729", "DOI": "10.1093/ejechocard/jen129", "volume": "9", "author": "T Kovacevic-Preradovic", "year": "2008", "unstructured": "Kovacevic-Preradovic T, Zuber M, Attenhofer Jost CH et al (2008) Anderson-Fabry disease: long-term echocardiographic follow-up under enzyme replacement therapy. Eur J Echocardiogr 9(6):729\u2013735", "journal-title": "Eur J Echocardiogr"}, {"issue": "1", "key": "25_CR16", "doi-asserted-by": "publisher", "first-page": "53", "DOI": "10.1002/mus.20550", "volume": "34", "author": "R Schiffmann", "year": "2006", "unstructured": "Schiffmann R, Hauer P, Freeman B et al (2006) Enzyme replacement therapy and intraepidermal innervation density in Fabry disease. Muscle Nerve 34(1):53\u201356", "journal-title": "Muscle Nerve"}, {"key": "25_CR17", "doi-asserted-by": "publisher", "first-page": "41", "DOI": "10.1186/1471-2377-8-41", "volume": "8", "author": "SN Gupta", "year": "2008", "unstructured": "Gupta SN, Ries M, Murray GJ et al (2008) Skin-impedance in Fabry Disease: a prospective, controlled, non-randomized clinical study. BMC Neurol 8:41", "journal-title": "BMC Neurol"}, {"issue": "6", "key": "25_CR18", "doi-asserted-by": "publisher", "first-page": "703", "DOI": "10.1002/mus.10497", "volume": "28", "author": "R Schiffmann", "year": "2003", "unstructured": "Schiffmann R, Floeter MK, Dambrosia JM et al (2003) Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease. Muscle Nerve 28(6):703\u2013710", "journal-title": "Muscle Nerve"}, {"issue": "3", "key": "25_CR19", "doi-asserted-by": "publisher", "first-page": "247", "DOI": "10.1136/jmg.2004.025791", "volume": "42", "author": "B Hoffmann", "year": "2005", "unstructured": "Hoffmann B, Garcia de Lorenzo A, Mehta A et al (2005) Effects of enzyme replacement therapy on pain and health related quality of life in patients with Fabry disease: data from FOS (Fabry Outcome Survey). J Med Genet 42(3):247\u2013252", "journal-title": "J Med Genet"}, {"issue": "6", "key": "25_CR20", "doi-asserted-by": "publisher", "first-page": "535", "DOI": "10.1097/AJP.0b013e318074c986", "volume": "23", "author": "B Hoffmann", "year": "2007", "unstructured": "Hoffmann B, Beck M, Sunder-Plassmann G et al (2007) Nature and prevalence of pain in Fabry disease and its response to enzyme replacement therapy-a retrospective analysis from the Fabry Outcome Survey. Clin J Pain 23(6):535\u2013542", "journal-title": "Clin J Pain"}, {"issue": "12", "key": "25_CR21", "doi-asserted-by": "publisher", "first-page": "1447", "DOI": "10.1016/j.cgh.2007.08.012", "volume": "5", "author": "B Hoffmann", "year": "2007", "unstructured": "Hoffmann B, Schwarz M, Mehta A, Keshav S (2007) Fabry Outcome Survey European Investigators. Gastrointestinal symptoms in 342 patients with Fabry disease: prevalence and response to enzyme replacement therapy. Clin Gastroenterol Hepatol 5(12):1447\u20131453", "journal-title": "Clin Gastroenterol Hepatol"}, {"issue": "9", "key": "25_CR22", "doi-asserted-by": "publisher", "first-page": "663", "DOI": "10.1111/j.1365-2362.2006.01701.x", "volume": "36", "author": "D Hajioff", "year": "2006", "unstructured": "Hajioff D, Hegemann S, Conti G et al (2006) Agalsidase alpha and hearing in Fabry disease: data from the Fabry Outcome Survey. Eur J Clin Invest 36(9):663\u2013667", "journal-title": "Eur J Clin Invest"}, {"issue": "4", "key": "25_CR23", "doi-asserted-by": "publisher", "first-page": "299", "DOI": "10.1111/j.1399-0004.2004.00219.x", "volume": "65", "author": "C Whybra", "year": "2004", "unstructured": "Whybra C, Kampmann C, Krummenauer F et al (2004) The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy. Clin Genet 65(4):299\u2013307", "journal-title": "Clin Genet"}, {"issue": "3", "key": "25_CR24", "doi-asserted-by": "publisher", "first-page": "260", "DOI": "10.1111/j.1399-0004.2008.01012.x", "volume": "74", "author": "R Parini", "year": "2008", "unstructured": "Parini R, Rigoldi M, Santus F et al (2008) Enzyme replacement therapy with agalsidase alfa in a cohort of Italian patients with Anderson-Fabry disease: testing the effects with the Mainz Severity Score Index. Clin Genet 74(3):260\u2013266", "journal-title": "Clin Genet"}, {"issue": "6", "key": "25_CR25", "doi-asserted-by": "publisher", "first-page": "441", "DOI": "10.1097/GIM.0b013e3181a23bec", "volume": "11", "author": "C Whybra", "year": "2009", "unstructured": "Whybra C, Miebach E, Mengel E et al (2009) A 4-year study of the efficacy and tolerability of enzyme replacement therapy with agalsidase alfa in 36 women with Fabry disease. Genet Med 11(6):441\u2013449", "journal-title": "Genet Med"}, {"issue": "1", "key": "25_CR26", "doi-asserted-by": "publisher", "first-page": "122", "DOI": "10.1111/j.1651-2227.2007.00029.x", "volume": "96", "author": "U Ramaswami", "year": "2007", "unstructured": "Ramaswami U, Wendt S, Pintos-Morell G et al (2007) Enzyme replacement therapy with agalsidase alfa in children with Fabry disease. Acta Paediatr 96(1):122\u2013127", "journal-title": "Acta Paediatr"}, {"issue": "3", "key": "25_CR27", "doi-asserted-by": "publisher", "first-page": "924", "DOI": "10.1542/peds.2005-2895", "volume": "118", "author": "M Ries", "year": "2006", "unstructured": "Ries M, Clarke JT, Whybra C et al (2006) Enzyme-replacement therapy with agalsidase alfa in children with Fabry disease. Pediatrics 118(3):924\u2013932", "journal-title": "Pediatrics"}, {"issue": "2", "key": "25_CR28", "doi-asserted-by": "publisher", "first-page": "S18", "DOI": "10.3949/ccjm.76.s2.04", "volume": "76", "author": "MS Lauer", "year": "2009", "unstructured": "Lauer MS (2009) Autonomic function and prognosis. Cleve Clin J Med 76(Suppl 2):S18\u2013S22", "journal-title": "Cleve Clin J Med"}, {"key": "25_CR29", "doi-asserted-by": "publisher", "first-page": "4", "DOI": "10.1186/1471-2377-2-4", "volume": "2", "author": "DF Moore", "year": "2002", "unstructured": "Moore DF, Altarescu G, Herscovitch P, Schiffmann R (2002) Enzyme replacement reverses abnormal cerebrovascular responses in Fabry disease. BMC Neurol 2:4", "journal-title": "BMC Neurol"}, {"issue": "2", "key": "25_CR30", "doi-asserted-by": "publisher", "first-page": "525", "DOI": "10.1161/hs0202.102601", "volume": "33", "author": "DF Moore", "year": "2002", "unstructured": "Moore DF, Altarescu G, Ling GS et al (2002) Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacement. Stroke 33(2):525\u2013531", "journal-title": "Stroke"}, {"issue": "13", "key": "25_CR31", "doi-asserted-by": "publisher", "first-page": "1506", "DOI": "10.1161/hc3801.096352", "volume": "104", "author": "DF Moore", "year": "2001", "unstructured": "Moore DF, Scott LT, Gladwin MT et al (2001) Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy. Circulation 104(13):1506\u20131512", "journal-title": "Circulation"}, {"issue": "2", "key": "25_CR32", "doi-asserted-by": "publisher", "first-page": "345", "DOI": "10.1093/ndt/gfi152", "volume": "21", "author": "R Schiffmann", "year": "2006", "unstructured": "Schiffmann R, Ries M, Timmons M, Flaherty JT, Brady RO (2006) Long-term therapy with agalsidase alfa for Fabry disease: safety and effects on renal function in a home infusion setting. Nephrol Dial Transplant 21(2):345\u2013354", "journal-title": "Nephrol Dial Transplant"}, {"issue": "4", "key": "25_CR33", "doi-asserted-by": "publisher", "first-page": "1589", "DOI": "10.1111/j.1523-1755.2004.00924.x", "volume": "66", "author": "GE Linthorst", "year": "2004", "unstructured": "Linthorst GE, Hollak CE, Donker-Koopman WE, Strijland A, Aerts JM (2004) Enzyme therapy for Fabry disease: neutralizing antibodies toward agalsidase alpha and beta. Kidney Int 66(4):1589\u20131595", "journal-title": "Kidney Int"}, {"issue": "1", "key": "25_CR34", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/j.ymgme.2008.10.013", "volume": "96", "author": "CE Hollak", "year": "2009", "unstructured": "Hollak CE, Linthorst GE (2009) Immune response to enzyme replacement therapy in Fabry disease: impact on clinical outcome? Mol Genet Metab 96(1):1\u20133", "journal-title": "Mol Genet Metab"}, {"issue": "2", "key": "25_CR35", "doi-asserted-by": "publisher", "first-page": "255", "DOI": "10.1517/14712590802658428", "volume": "9", "author": "M Beck", "year": "2009", "unstructured": "Beck M (2009) Agalsidase alfa for the treatment of Fabry disease: new data on clinical efficacy and safety. Expert Opin Biol Ther 9(2):255\u2013261", "journal-title": "Expert Opin Biol Ther"}, {"issue": "5", "key": "25_CR36", "doi-asserted-by": "publisher", "first-page": "1576", "DOI": "10.1681/ASN.2006111263", "volume": "18", "author": "R Schiffmann", "year": "2007", "unstructured": "Schiffmann R, Askari H, Timmons M et al (2007) Weekly enzyme replacement therapy may slow decline of renal function in patients with Fabry disease who are on long-term biweekly dosing. J Am Soc Nephrol 18(5):1576\u20131583", "journal-title": "J Am Soc Nephrol"}, {"issue": "8", "key": "25_CR37", "doi-asserted-by": "publisher", "first-page": "548", "DOI": "10.1136/jmg.2008.065904", "volume": "46", "author": "A Mehta", "year": "2009", "unstructured": "Mehta A, Clarke JT, Giugliani R et al (2009) Natural course of Fabry disease: changing pattern of causes of death in FOS \u2013 the Fabry Outcome Survey. J Med Genet 46(8):548\u2013552", "journal-title": "J Med Genet"}, {"issue": "3", "key": "25_CR38", "doi-asserted-by": "publisher", "first-page": "307", "DOI": "10.1016/j.ymgme.2006.11.008", "volume": "90", "author": "GJ Murray", "year": "2007", "unstructured": "Murray GJ, Anver MR, Kennedy MA, Quirk JM, Schiffmann R (2007) Cellular and tissue distribution of intravenously administered agalsidase alfa. Mol Genet Metab 90(3):307\u2013312", "journal-title": "Mol Genet Metab"}, {"issue": "2", "key": "25_CR39", "doi-asserted-by": "publisher", "first-page": "303", "DOI": "10.1007/s10545-009-1055-6", "volume": "32", "author": "C Auray-Blais", "year": "2009", "unstructured": "Auray-Blais C, Millington DS, Young SP, Clarke JT, Schiffmann R (2009) Proposed high-risk screening protocol for Fabry disease in patients with renal and vascular disease. J Inherit Metab Dis 32(2):303\u2013308", "journal-title": "J Inherit Metab Dis"}, {"issue": "4", "key": "25_CR40", "doi-asserted-by": "publisher", "first-page": "508", "DOI": "10.1007/s10545-008-0900-3", "volume": "31", "author": "P Vylet\u2019al", "year": "2008", "unstructured": "Vylet\u2019al P, H\u016flkov\u00e1 H, Zivn\u00e1 M et al (2008) Abnormal expression and processing of uromodulin in Fabry disease reflects tubular cell storage alteration and is reversible by enzyme replacement therapy. J Inherit Metab Dis 31(4):508\u2013517", "journal-title": "J Inherit Metab Dis"}, {"issue": "7", "key": "25_CR41", "doi-asserted-by": "publisher", "first-page": "e", "DOI": "10.1161/ATVBAHA.107.143511", "volume": "27", "author": "MP Gelderman", "year": "2007", "unstructured": "Gelderman MP, Schiffmann R, Simak J (2007) Elevated endothelial microparticles in Fabry children decreased after enzyme replacement therapy. Arterioscler Thromb Vasc Biol 27(7):e", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"issue": "9", "key": "25_CR42", "doi-asserted-by": "publisher", "first-page": "2426", "DOI": "10.1681/ASN.2007070783", "volume": "18", "author": "C Wanner", "year": "2007", "unstructured": "Wanner C, Breunig F (2007) Fabry nephropathy and the case for adjunctive renal therapy. J Am Soc Nephrol 18(9):2426\u20132428", "journal-title": "J Am Soc Nephrol"}, {"issue": "1", "key": "25_CR43", "doi-asserted-by": "publisher", "first-page": "21", "DOI": "10.2217/17455111.2.1.21", "volume": "2", "author": "GM Pastores", "year": "2008", "unstructured": "Pastores GM (2008) Therapeutic options for childhood-onset lysosomal storage disorders. Pediatr Health 2(1):21\u201332", "journal-title": "Pediatr Health"}], "container-title": ["Fabry Disease"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-90-481-9033-1_25", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 17]], "date-time": "2019-03-17T15:56:12Z", "timestamp": 1552838172000}, "score": 22.717487, "issued": {"date-parts": [[2010]]}, "ISBN": ["9789048190324", "9789048190331"], "references-count": 43, "URL": "http://dx.doi.org/10.1007/978-90-481-9033-1_25", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T17:19:15Z", "timestamp": 1574270355412}, "reference-count": 7, "publisher": "BMJ", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Archives of Disease in Childhood"], "published-print": {"date-parts": [[1993, 12, 1]]}, "DOI": "10.1136/adc.69.6.637", "type": "journal-article", "created": {"date-parts": [[2008, 12, 22]], "date-time": "2008-12-22T22:39:16Z", "timestamp": 1229985556000}, "page": "637-638", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Commentary"], "prefix": "10.1136", "volume": "69", "author": [{"given": "M.", "family": "Levin", "sequence": "first", "affiliation": []}], "member": "239", "reference": [{"key": "ref_1", "doi-asserted-by": "crossref", "first-page": "1055", "DOI": "10.1016/S0140-6736(84)91504-6", "article-title": "High dose intravenous gammaglobulin for Kawasaki disease", "volume": "ii:", "author": "Furusho, K.; Kamiya, T.; Nakano, H.", "year": "1984", "unstructured": "Furusho K, Kamiya T, Nakano H, et al. High dose intravenous gammaglobulin for Kawasaki disease. Lancet 1984; ii: 1055-8.", "journal-title": "Lancet"}, {"key": "ref_2", "doi-asserted-by": "crossref", "first-page": "710", "DOI": "10.1016/S0022-3476(87)80007-0", "article-title": "High dose gammaglobulin therapy for Kawasaki disease", "volume": "110", "author": "Nagashima, M.; Matsushima, M.; Matsuoka, H.; Ogawa, A.; Okumwa, N.", "year": "1987", "unstructured": "Nagashima M, Matsushima M, Matsuoka H, Ogawa A, Okumwa N. High dose gammaglobulin therapy for Kawasaki disease. JPediatr 1987; 110: 710-2.", "journal-title": "JPediatr"}, {"key": "ref_3", "doi-asserted-by": "crossref", "first-page": "341", "DOI": "10.1056/NEJM198608073150601", "article-title": "The treatment of Kawasaki syndrome with intravenous gammaglobulin", "volume": "315", "author": "Newburger, J.W.; Takahashi, M.; Burns, J.C.", "year": "1986", "unstructured": "Newburger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gammaglobulin. NEngIlMed 1986; 315: 341-7.", "journal-title": "NEngIlMed"}, {"key": "ref_4", "doi-asserted-by": "crossref", "first-page": "1633", "DOI": "10.1056/NEJM199106063242305", "article-title": "A single intravenous infusion of gammaglobulin as compared with four infusions in the treatment of acute Kawasaki syndrome", "volume": "324", "author": "Newburger, J.W.; Takahashi, M.; Beiser, A.S.", "year": "1991", "unstructured": "Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gammaglobulin as compared with four infusions in the treatment of acute Kawasaki syndrome. NEngIlMed 1991; 324: 1633-9.", "journal-title": "NEngIlMed"}, {"key": "ref_5", "first-page": "663", "article-title": "Management of Kawasaki syndrome: a consensus statement prepared by North American participants of the Third International Kawasaki Disease Symposium", "volume": "8", "author": "Shulman, S.T.; Bass, J.L.; Bierman, F.", "year": "1988", "unstructured": "Shulman ST, Bass JL, Bierman F, et al. Management of Kawasaki syndrome: a consensus statement prepared by North American participants of the Third International Kawasaki Disease Symposium, Tokyo, Japan, December 1988. Pediatr Infect Dis J 1989; 8: 663-7.", "journal-title": "Pediatr Infect Dis J"}, {"key": "ref_6", "first-page": "828", "article-title": "Coronary artery involvement in Kawasaki syndrome in Manhattan, New York: risk factors and role of aspirin", "volume": "80", "author": "Ichida, F.; Fatica, N.S.; Engle, M.A.", "year": "1987", "unstructured": "Ichida F, Fatica NS, Engle MA, et al. Coronary artery involvement in Kawasaki syndrome in Manhattan, New York: risk factors and role of aspirin. Pediatrics 1987; 80: 828-35.", "journal-title": "Pediatrics"}, {"key": "ref_7", "first-page": "170", "article-title": "Evaluation method for the degree of seriousness in Kawasaki disease", "volume": "25", "author": "Asai, T.", "year": "1983", "unstructured": "Asai T. Evaluation method for the degree of seriousness in Kawasaki disease. Acta PaediatrJpn 1983; 25: 170-5", "journal-title": "Acta PaediatrJpn"}], "container-title": ["Archives of Disease in Childhood"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1136/adc.69.6.637", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 2]], "date-time": "2019-02-02T11:37:28Z", "timestamp": 1549107448000}, "score": 19.522861, "issued": {"date-parts": [[1993, 12, 1]]}, "references-count": 7, "journal-issue": {"published-print": {"date-parts": [[1993, 12, 1]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.1136/adc.69.6.637", "relation": {"cites": []}, "ISSN": ["0003-9888", "1468-2044"], "issn-type": [{"value": "0003-9888", "type": "print"}, {"value": "1468-2044", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T09:03:49Z", "timestamp": 1574154229547}, "reference-count": 23, "publisher": "Wiley", "issue": "1", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 4638, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1034/j.1399-0004.2003.630107.x", "type": "journal-article", "created": {"date-parts": [[2003, 3, 11]], "date-time": "2003-03-11T11:30:48Z", "timestamp": 1047382248000}, "page": "46-52", "source": "Crossref", "is-referenced-by-count": 30, "title": ["Fabry disease: a functional and anatomical study of cardiac manifestations in 20 hemizygous male patients"], "prefix": "10.1111", "volume": "63", "author": [{"given": "M", "family": "Senechal", "sequence": "first", "affiliation": []}, {"given": "DP", "family": "Germain", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2002, 12, 20]]}, "reference": [{"key": "10.1034/j.1399-0004.2003.630107.x-BIB1|cit2", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1051/jbio/2002196020161", "article-title": "Fabry disease (\u03b1-galactosidase A deficiency): pathophysiology, clinical signs and genetics aspects", "volume": "196", "author": "Germain", "year": "2002", "journal-title": "J Soc Biol"}, {"key": "10.1034/j.1399-0004.2003.630107.x-BIB2|cit3", "doi-asserted-by": "crossref", "first-page": "249", "DOI": "10.1001/jama.281.3.249", "article-title": "Prevalence of lysosomal storage disorders", "volume": "281", "author": "Meikle", "year": "1999", "journal-title": "J Am Med Assoc"}, {"key": "10.1034/j.1399-0004.2003.630107.x-BIB3|cit4", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1056/NEJM200107053450102", "article-title": "Safety and efficacy of recombinant human \u03b1-galactosidase replacement therapy in Fabry's disease", "volume": "345", "author": "Eng", "year": "2001", "journal-title": "New Engl J Med"}, {"key": "10.1034/j.1399-0004.2003.630107.x-BIB4|cit5", "doi-asserted-by": "crossref", "first-page": "2743", "DOI": "10.1001/jama.285.21.2743", "article-title": "Enzyme replacement therapy in Fabry disease: a randomized controlled trial", "volume": "285", "author": "Schiffmann", "year": "2001", "journal-title": "J Am Med Assoc"}, {"key": "10.1034/j.1399-0004.2003.630107.x-BIB5|cit6", "doi-asserted-by": "crossref", "first-page": "450", "DOI": "10.1016/0002-9149(86)90771-X", "article-title": "Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings", "volume": "57", "author": "Devereux", "year": "1986", "journal-title": "Am J Cardiol"}, {"key": "10.1034/j.1399-0004.2003.630107.x-BIB6|cit7", "doi-asserted-by": "crossref", "first-page": "879", "DOI": "10.1016/0735-1097(94)00473-4", "article-title": "Prognosis of left ventricular geometric pattern in the Framingham Heart Study", "volume": "25", "author": "Krumholz", "year": "1995", "journal-title": "J Am Coll Cardiol"}, {"key": "10.1034/j.1399-0004.2003.630107.x-BIB7|cit8", "doi-asserted-by": "crossref", "first-page": "97", "DOI": "10.1161/01.HYP.9.2_Pt_2.II97", "article-title": "Recommendations concerning use of echocardiography in hypertension and general population research", "volume": "9", "author": "Devereux", "year": "1987", "journal-title": "Hypertension"}, {"key": "10.1034/j.1399-0004.2003.630107.x-BIB8|cit9", "doi-asserted-by": "crossref", "first-page": "1753", "DOI": "10.1016/0735-1097(96)00088-5", "article-title": "A practical guide to assessment of ventricular diastolic function using Doppler echocardiography", "volume": "27", "author": "Cohen", "year": "1996", "journal-title": "J Am Coll Cardiol"}, {"key": "10.1034/j.1399-0004.2003.630107.x-BIB9|cit10", "doi-asserted-by": "crossref", "first-page": "657", "DOI": "10.1161/01.CIR.70.4.657", "article-title": "Non-invasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation", "volume": "70", "author": "Yock", "year": "1984", "journal-title": "Circulation"}, {"key": "10.1034/j.1399-0004.2003.630107.x-BIB10|cit11", "doi-asserted-by": "crossref", "first-page": "1233", "DOI": "10.1016/S0002-9149(99)80769-3", "article-title": "Relation between electrocardiography and echocardiography for left ventricular mass in mild systemic hypertension", "volume": "75", "author": "Crow", "year": "1995", "journal-title": "Am J Cardiol"}, {"key": "10.1034/j.1399-0004.2003.630107.x-BIB11|cit12", "doi-asserted-by": "crossref", "first-page": "449", "DOI": "10.1007/BF01606034", "article-title": "Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease", "volume": "417", "author": "Elleder", "year": "1990", "journal-title": "Virchows Arch Pathol Anat Histopathol"}, {"key": "10.1034/j.1399-0004.2003.630107.x-BIB12|cit13", "doi-asserted-by": "crossref", "first-page": "1523", "DOI": "10.1161/01.ATV.18.10.1523", "article-title": "Sphingolipids in atherosclerosis and vascular biology", "volume": "18", "author": "Chatterjee", "year": "1998", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "10.1034/j.1399-0004.2003.630107.x-BIB13|cit14", "doi-asserted-by": "crossref", "first-page": "1101", "DOI": "10.1067/mhj.2000.105105", "article-title": "New insights in cardiac structural changes in patients with Fabry's disease", "volume": "139", "author": "Linhart", "year": "2000", "journal-title": "Am Heart J"}, {"key": "10.1034/j.1399-0004.2003.630107.x-BIB14|cit15", "doi-asserted-by": "crossref", "first-page": "418", "DOI": "10.1016/0002-9149(81)90068-0", "article-title": "Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients", "volume": "48", "author": "Maron", "year": "1981", "journal-title": "Am J Cardiol"}, {"key": "10.1034/j.1399-0004.2003.630107.x-BIB15|cit16", "doi-asserted-by": "crossref", "first-page": "1407", "DOI": "10.1161/01.CIR.0000012626.81324.38", "article-title": "Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy", "volume": "105", "author": "Sachdev", "year": "2002", "journal-title": "Circulation"}, {"key": "10.1034/j.1399-0004.2003.630107.x-BIB16|cit17", "doi-asserted-by": "crossref", "first-page": "75", "DOI": "10.1023/A:1012428009627", "article-title": "Cardiac manifestations in Fabry disease", "volume": "24", "author": "Linhart", "year": "2001", "journal-title": "J Inherit Metab Dis"}, {"key": "10.1034/j.1399-0004.2003.630107.x-BIB17|cit18", "doi-asserted-by": "crossref", "first-page": "1157", "DOI": "10.1016/S0735-1097(86)80238-8", "article-title": "Echocardiographic abnormalities and disease severity in Fabry's disease", "volume": "7", "author": "Goldman", "year": "1986", "journal-title": "J Am Coll Cardiol"}, {"key": "10.1034/j.1399-0004.2003.630107.x-BIB18|cit19", "doi-asserted-by": "crossref", "first-page": "276", "DOI": "10.1111/j.1399-0004.1986.tb01255.x", "article-title": "Cardiovascular manifestations in Fabry's disease", "volume": "29", "author": "Sakuraba", "year": "1986", "journal-title": "Clin Genet"}, {"key": "10.1034/j.1399-0004.2003.630107.x-BIB19|cit20", "doi-asserted-by": "crossref", "first-page": "203", "DOI": "10.1016/0002-9149(94)90106-6", "article-title": "Electrophysiologic findings in Fabry's disease with a short PR interval", "volume": "74", "author": "Pochis", "year": "1994", "journal-title": "Am J Cardiol"}, {"key": "10.1034/j.1399-0004.2003.630107.x-BIB20|cit21", "doi-asserted-by": "crossref", "first-page": "785", "DOI": "10.1161/01.CIR.92.4.785", "article-title": "Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the Cardia Study", "volume": "92", "author": "Maron", "year": "1995", "journal-title": "Circulation"}, {"key": "10.1034/j.1399-0004.2003.630107.x-BIB21|cit22", "doi-asserted-by": "crossref", "first-page": "288", "DOI": "10.1056/NEJM199508033330504", "article-title": "An atypical variant of Fabry's disease in men with left ventricular hypertrophy", "volume": "333", "author": "Nakao", "year": "1995", "journal-title": "New Engl J Med"}, {"key": "10.1034/j.1399-0004.2003.630107.x-BIB22|cit23", "unstructured": "Germain DP Avan P Chassaing A Bonfils P Patients affected with Fabry disease have an increased incidence of progressive hearing loss and sudden deafness. an investigation of twenty-two consecutive hemizygous male patients BMC Med Genet 2002 3 10", "DOI": "10.1186/1471-2350-3-10", "doi-asserted-by": "crossref"}, {"key": "10.1034/j.1399-0004.2003.630107.x-BIB23|cit24", "unstructured": "Germain DP Shabbeer J Cotigny S Desnick RJ Fabry disease. Twenty novel \u03b1-galactosidase A mutations and genotype-phenotype correlations in classical and variant phenotypes Mol Med 2002"}], "container-title": ["Clinical Genetics"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1034%2Fj.1399-0004.2003.630107.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 2, 2]], "date-time": "2018-02-02T09:08:55Z", "timestamp": 1517562535000}, "score": 19.444296, "subtitle": ["Fabry disease: cardiac abnormalities in male patients"], "issued": {"date-parts": [[2002, 12, 20]]}, "references-count": 23, "journal-issue": {"issue": "1"}, "URL": "http://dx.doi.org/10.1034/j.1399-0004.2003.630107.x", "relation": {"cites": []}, "ISSN": ["0009-9163", "1399-0004"], "issn-type": [{"value": "0009-9163", "type": "print"}, {"value": "1399-0004", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T20:19:17Z", "timestamp": 1574453957760}, "reference-count": 11, "publisher": "Wiley", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 3164, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1111/j.1651-2227.2005.tb02104.x", "type": "journal-article", "created": {"date-parts": [[2010, 8, 7]], "date-time": "2010-08-07T04:19:03Z", "timestamp": 1281154743000}, "page": "15-18", "source": "Crossref", "is-referenced-by-count": 0, "title": ["The right ventricle in Fabry disease"], "prefix": "10.1111", "volume": "94", "author": [{"given": "C", "family": "Kampmann", "sequence": "first", "affiliation": []}, {"given": "FA", "family": "Baehner", "sequence": "additional", "affiliation": []}, {"given": "C", "family": "Whybra", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Bajbouj", "sequence": "additional", "affiliation": []}, {"given": "K", "family": "Baron", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Knuf", "sequence": "additional", "affiliation": []}, {"given": "CM", "family": "Wiethoff", "sequence": "additional", "affiliation": []}, {"given": "H", "family": "Tr\u00fcbel", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Beck", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2007, 1, 2]]}, "reference": [{"key": "10.1111/j.1651-2227.2005.tb02104.x-BIB1|cit1", "first-page": "415", "article-title": "Natural history of the Anderson-Fabry disease related cardiomyopathy", "volume": "71", "author": "Baehner", "year": "2002", "journal-title": "Am J Hum Genet"}, {"key": "10.1111/j.1651-2227.2005.tb02104.x-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "786", "DOI": "10.1007/s00392-002-0848-5", "article-title": "The heart in Anderson Fabry disease", "volume": "91", "author": "Kampmann", "year": "2002", "journal-title": "Z Kardiol"}, {"key": "10.1111/j.1651-2227.2005.tb02104.x-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "S147", "DOI": "10.1097/01.ASN.0000015238.98011.AF", "article-title": "Cardiac involvement in Anderson-Fabry disease", "volume": "13", "author": "Kampmann", "year": "2002", "journal-title": "J Am Soc Nephrol"}, {"key": "10.1111/j.1651-2227.2005.tb02104.x-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "75", "DOI": "10.1023/A:1012428009627", "article-title": "Cardiac manifestations in Fabry disease", "volume": "24", "author": "Linhart", "year": "2001", "journal-title": "J Inherit Metab Dis"}, {"key": "10.1111/j.1651-2227.2005.tb02104.x-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "334", "DOI": "10.1007/BF00296520", "article-title": "A histochemical and electron microscopic study of skeletal and cardiac muscle from a Fabry disease patient and carrier", "volume": "90", "author": "Uchino", "year": "1995", "journal-title": "Acta Neuropathol (Berl)"}, {"key": "10.1111/j.1651-2227.2005.tb02104.x-BIB6|cit6", "first-page": "46", "article-title": "Sequelae of storage in Fabry disease - pathology and comparison with other lysosomal storage diseases", "volume": "92(443)", "author": "Elleder", "year": "2003", "journal-title": "Acta Paediatr Suppl"}, {"key": "10.1111/j.1651-2227.2005.tb02104.x-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "750", "DOI": "10.1136/jmg.38.11.750", "article-title": "Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males", "volume": "38", "author": "MacDermot", "year": "2001", "journal-title": "J Med Genet"}, {"key": "10.1111/j.1651-2227.2005.tb02104.x-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "212", "DOI": "10.1111/j.1475-097X.2004.00550.x", "article-title": "Right ventricular long-axis function in relation to left ventricular systolic function", "volume": "24", "author": "Emilsson", "year": "2004", "journal-title": "Clin Physiol Funct Imaging"}, {"key": "10.1111/j.1651-2227.2005.tb02104.x-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "1668", "DOI": "10.1016/S0735-1097(02)02380-X", "article-title": "Cardiac manifestations of Anderson-Fabry disease in heterozygous females", "volume": "40", "author": "Kampmann", "year": "2002", "journal-title": "J Am Coll Cardiol"}, {"key": "10.1111/j.1651-2227.2005.tb02104.x-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "236", "DOI": "10.1111/j.1365-2362.2004.01309.x", "article-title": "Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey", "volume": "34", "author": "Mehta", "year": "2004", "journal-title": "Eur J Clin Invest"}, {"key": "10.1111/j.1651-2227.2005.tb02104.x-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "2151", "DOI": "10.1016/j.ehj.2003.09.017", "article-title": "Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium", "volume": "24", "author": "Moon", "year": "2003", "journal-title": "Eur Heart J"}], "container-title": ["Acta Paediatrica"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1651-2227.2005.tb02104.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 1]], "date-time": "2019-06-01T12:02:14Z", "timestamp": 1559390534000}, "score": 19.248083, "subtitle": ["The right ventricle in Fabry disease"], "issued": {"date-parts": [[2007, 1, 2]]}, "references-count": 11, "URL": "http://dx.doi.org/10.1111/j.1651-2227.2005.tb02104.x", "relation": {"cites": []}, "ISSN": ["0803-5253"], "issn-type": [{"value": "0803-5253", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T23:39:07Z", "timestamp": 1574293147428}, "reference-count": 1, "publisher": "Elsevier", "isbn-type": [{"value": "9780124060616", "type": "print"}], "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2006, 1, 1]], "date-time": "2006-01-01T00:00:00Z", "timestamp": 1136073600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2006]]}, "DOI": "10.1016/b978-012406061-6/50007-2", "type": "book-chapter", "created": {"date-parts": [[2007, 5, 16]], "date-time": "2007-05-16T13:37:34Z", "timestamp": 1179322654000}, "page": "23", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Anderson-Fabry Disease"], "prefix": "10.1016", "author": [{"given": "M. GABRIEL", "family": "KHAN", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Encyclopedia of Heart Diseases"], "link": [{"URL": "https://api.elsevier.com/content/article/PII:B9780124060616500072?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:B9780124060616500072?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 7]], "date-time": "2019-01-07T16:54:44Z", "timestamp": 1546880084000}, "score": 19.214035, "issued": {"date-parts": [[2006]]}, "ISBN": ["9780124060616"], "references-count": 1, "URL": "http://dx.doi.org/10.1016/b978-012406061-6/50007-2"}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T20:19:39Z", "timestamp": 1574453979055}, "reference-count": 19, "publisher": "Wiley", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 3164, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1111/j.1651-2227.2005.tb02105.x", "type": "journal-article", "created": {"date-parts": [[2010, 8, 7]], "date-time": "2010-08-07T05:33:34Z", "timestamp": 1281159214000}, "page": "19-23", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Measurement of renal function in patients with Fabry disease"], "prefix": "10.1111", "volume": "94", "author": [{"given": "J", "family": "Kleinert", "sequence": "first", "affiliation": []}, {"given": "M", "family": "Lorenz", "sequence": "additional", "affiliation": []}, {"given": "A -C", "family": "Hauser", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Becherer", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Staudenherz", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "F\u00f6dinger", "sequence": "additional", "affiliation": []}, {"given": "G", "family": "Sunder-Plassmann", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2007, 1, 2]]}, "reference": [{"key": "10.1111/j.1651-2227.2005.tb02105.x-BIB1|cit1", "author": "Kleinert", "first-page": "66", "article-title": "Therapy of Fabry disease", "journal-title": "Kidney Int"}, {"key": "10.1111/j.1651-2227.2005.tb02105.x-BIB2|cit2", "first-page": "S1", "article-title": "K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification", "volume": "39", "author": "National Kidney Foundation Kidney Disease Outcome Quality Initiative (K/DOQI) Advisory Board", "year": "2002", "journal-title": "Am J Kidney Dis"}, {"key": "10.1111/j.1651-2227.2005.tb02105.x-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "55", "DOI": "10.3810/pgm.2001.12.1065", "article-title": "Estimating the glomerular filtration rate. Dos and don'ts for assessing kidney function", "volume": "110", "author": "Manjunath", "year": "2001", "journal-title": "Postgrad Med"}, {"key": "10.1111/j.1651-2227.2005.tb02105.x-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "31", "DOI": "10.1159/000180580", "article-title": "Prediction of creatinine clearance from serum creatinine", "volume": "16", "author": "Cockcroft", "year": "1976", "journal-title": "Nephron"}, {"key": "10.1111/j.1651-2227.2005.tb02105.x-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "1505", "DOI": "10.1056/NEJMcp013462", "article-title": "Clinical practice. Nondiabetic kidney disease", "volume": "347", "author": "Levey", "year": "2002", "journal-title": "N Engl J Med"}, {"key": "10.1111/j.1651-2227.2005.tb02105.x-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "461", "DOI": "10.7326/0003-4819-130-6-199903160-00002", "article-title": "A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group", "volume": "130", "author": "Levey", "year": "1999", "journal-title": "Ann Intern Med"}, {"key": "10.1111/j.1651-2227.2005.tb02105.x-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "112", "DOI": "10.1053/j.ajkd.2003.09.026", "article-title": "Measured and estimated GFR in healthy potential kidney donors", "volume": "43", "author": "Rule", "year": "2004", "journal-title": "Am J Kidney Dis"}, {"key": "10.1111/j.1651-2227.2005.tb02105.x-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "2573", "DOI": "10.1097/01.ASN.0000088721.98173.4B", "article-title": "A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease", "volume": "14", "author": "Lin", "year": "2003", "journal-title": "J Am Soc Nephrol"}, {"key": "10.1111/j.1651-2227.2005.tb02105.x-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1056/NEJM200107053450102", "article-title": "Safety and efficacy of recombinant human alpha-galactosidase alpha replacement therapy in Fabry's disease", "volume": "345", "author": "Eng", "year": "2001", "journal-title": "N Engl J Med"}, {"key": "10.1111/j.1651-2227.2005.tb02105.x-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "2743", "DOI": "10.1001/jama.285.21.2743", "article-title": "Enzyme replacement therapy in Fabry disease: a randomized controlled trial", "volume": "285", "author": "Schiffmann", "year": "2001", "journal-title": "JAMA"}, {"key": "10.1111/j.1651-2227.2005.tb02105.x-BIB11|cit11", "first-page": "S630", "article-title": "Stabilization of renal function after enzyme replacement therapy in Fabry disease", "volume": "18", "author": "Waldek", "year": "2003", "journal-title": "Nephrol Dial Transplant"}, {"key": "10.1111/j.1651-2227.2005.tb02105.x-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "221", "DOI": "10.1053/ajkd.2002.34487", "article-title": "Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis", "volume": "40", "author": "Dharnidharka", "year": "2002", "journal-title": "Am J Kidney Dis"}, {"key": "10.1111/j.1651-2227.2005.tb02105.x-BIB13|cit13", "first-page": "S632", "article-title": "Enzyme replacement therapy in Fabry disease: what is the best marker of renal function", "volume": "18", "author": "Feriozzi", "year": "2003", "journal-title": "Nephrol Dial Transplant"}, {"key": "10.1111/j.1651-2227.2005.tb02105.x-BIB14|cit14", "author": "Hauser", "article-title": "High prevalence of subclinical hypothyroidism in patients with Fabry disease", "journal-title": "Clin Endocrinol"}, {"key": "10.1111/j.1651-2227.2005.tb02105.x-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "1944", "DOI": "10.1046/j.1523-1755.2003.00925.x", "article-title": "Impact of thyroid dysfunction on serum cystatin C", "volume": "63", "author": "Fricker", "year": "2003", "journal-title": "Kidney Int"}, {"key": "10.1111/j.1651-2227.2005.tb02105.x-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "87", "DOI": "10.1016/j.cccn.2003.07.022", "article-title": "Serum cystatin C is sensitive to small changes in thyroid function", "volume": "338", "author": "Wiesli", "year": "2003", "journal-title": "Clin Chim Acta"}, {"key": "10.1111/j.1651-2227.2005.tb02105.x-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "293", "DOI": "10.1111/j.1365-2265.1989.tb02238.x", "article-title": "Renal function and electrolyte levels in hyperthyroidism: urinary protein excretion and the plasma concentrations of urea, creatinine, uric acid, hydrogen ion and electrolytes", "volume": "30", "author": "Ford", "year": "1989", "journal-title": "Clin Endocrinol (Oxf)"}, {"key": "10.1111/j.1651-2227.2005.tb02105.x-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "79", "DOI": "10.1001/archinte.159.1.79", "article-title": "Consistent reversible elevations of serum creatinine levels in severe hypothyroidism", "volume": "159", "author": "Kreisman", "year": "1999", "journal-title": "Arch Intern Med"}, {"key": "10.1111/j.1651-2227.2005.tb02105.x-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "1416", "DOI": "10.1111/j.1523-1755.2004.00517.x", "article-title": "Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement", "volume": "65", "author": "Knight", "year": "2004", "journal-title": "Kidney Int"}], "container-title": ["Acta Paediatrica"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1651-2227.2005.tb02105.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 3]], "date-time": "2019-03-03T07:00:08Z", "timestamp": 1551596408000}, "score": 19.045216, "subtitle": ["Renal function in Fabry disease"], "issued": {"date-parts": [[2007, 1, 2]]}, "references-count": 19, "URL": "http://dx.doi.org/10.1111/j.1651-2227.2005.tb02105.x", "relation": {"cites": []}, "ISSN": ["0803-5253"], "issn-type": [{"value": "0803-5253", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T17:17:30Z", "timestamp": 1574270250064}, "reference-count": 0, "publisher": "BMJ", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Archives of Disease in Childhood"], "published-print": {"date-parts": [[1985, 5, 1]]}, "DOI": "10.1136/adc.60.5.502", "type": "journal-article", "created": {"date-parts": [[2008, 12, 22]], "date-time": "2008-12-22T21:51:33Z", "timestamp": 1229982693000}, "page": "502-502", "source": "Crossref", "is-referenced-by-count": 0, "title": ["A Practical Guide to Pediatric Intensive Care"], "prefix": "10.1136", "volume": "60", "author": [{"given": "M", "family": "Levin", "sequence": "first", "affiliation": []}], "member": "239", "container-title": ["Archives of Disease in Childhood"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1136/adc.60.5.502", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T18:34:26Z", "timestamp": 1482518066000}, "score": 18.895893, "issued": {"date-parts": [[1985, 5, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1985, 5, 1]]}, "issue": "5"}, "URL": "http://dx.doi.org/10.1136/adc.60.5.502", "ISSN": ["0003-9888", "1468-2044"], "issn-type": [{"value": "0003-9888", "type": "print"}, {"value": "1468-2044", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T03:54:28Z", "timestamp": 1574481268414}, "reference-count": 30, "publisher": "Wiley", "issue": "4", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 1693, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2011, 4]]}, "DOI": "10.1111/j.1651-2227.2010.02101.x", "type": "journal-article", "created": {"date-parts": [[2010, 11, 29]], "date-time": "2010-11-29T05:19:10Z", "timestamp": 1291007950000}, "page": "605-611", "source": "Crossref", "is-referenced-by-count": 13, "title": ["Safety of agalsidase alfa in patients with Fabry disease under 7\u2003years"], "prefix": "10.1111", "volume": "100", "author": [{"given": "U", "family": "Ramaswami", "sequence": "first", "affiliation": []}, {"given": "R", "family": "Parini", "sequence": "additional", "affiliation": []}, {"given": "C", "family": "Kampmann", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Beck", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2011, 1, 12]]}, "reference": [{"key": "10.1111/j.1651-2227.2010.02101.x-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "65", "DOI": "10.1016/j.pharmthera.2009.01.003", "article-title": "Fabry disease", "volume": "122", "author": "Schiffmann", "year": "2009", "journal-title": "Pharmacol Ther"}, {"key": "10.1111/j.1651-2227.2010.02101.x-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "249", "DOI": "10.1001/jama.281.3.249", "article-title": "Prevalence of lysosomal storage disorders", "volume": "281", "author": "Meikle", "year": "1999", "journal-title": "JAMA"}, {"key": "10.1111/j.1651-2227.2010.02101.x-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "31", "DOI": "10.1086/504601", "article-title": "High incidence of later-onset Fabry disease revealed by newborn screening", "volume": "79", "author": "Spada", "year": "2006", "journal-title": "Am J Hum Genet"}, {"key": "10.1111/j.1651-2227.2010.02101.x-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "86", "DOI": "10.1080/08035250500275022", "article-title": "Clinical manifestations of Fabry disease in children: data from the Fabry Outcome Survey", "volume": "95", "author": "Ramaswami", "year": "2006", "journal-title": "Acta Paediatr"}, {"key": "10.1111/j.1651-2227.2010.02101.x-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "767", "DOI": "10.1007/s00431-003-1299-3", "article-title": "The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents", "volume": "162", "author": "Ries", "year": "2003", "journal-title": "Eur J Pediatr"}, {"key": "10.1111/j.1651-2227.2010.02101.x-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "e344", "DOI": "10.1542/peds.2004-1678", "article-title": "Pediatric Fabry disease", "volume": "115", "author": "Ries", "year": "2005", "journal-title": "Pediatrics"}, {"key": "10.1111/j.1651-2227.2010.02101.x-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "1355", "DOI": "10.1007/s00431-009-0937-9", "article-title": "Fabry disease in children and the effects of enzyme replacement treatment", "volume": "168", "author": "Pintos-Morell", "year": "2009", "journal-title": "Eur J Pediatr"}, {"key": "10.1111/j.1651-2227.2010.02101.x-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "713", "DOI": "10.1097/GIM.0b013e3181f13b75", "article-title": "Effects of enzyme replacement therapy in Fabry disease - a comprehensive review of the medical literature", "volume": "12", "author": "Lidove", "year": "2010", "journal-title": "Genet Med"}, {"key": "10.1111/j.1651-2227.2010.02101.x-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "122", "DOI": "10.1111/j.1651-2227.2007.00029.x", "article-title": "Enzyme replacement therapy with agalsidase alfa in children with Fabry disease", "volume": "96", "author": "Ramaswami", "year": "2007", "journal-title": "Acta Paediatr"}, {"key": "10.1111/j.1651-2227.2010.02101.x-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "924", "DOI": "10.1542/peds.2005-2895", "article-title": "Enzyme-replacement therapy with agalsidase alfa in children with Fabry disease", "volume": "118", "author": "Ries", "year": "2006", "journal-title": "Pediatrics"}, {"key": "10.1111/j.1651-2227.2010.02101.x-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "832", "DOI": "10.1016/j.jpeds.2009.11.007", "article-title": "Four-year prospective clinical trial of agalsidase alfa in children with Fabry disease", "volume": "156", "author": "Schiffmann", "year": "2010", "journal-title": "J Pediatr"}, {"key": "10.1111/j.1651-2227.2010.02101.x-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "563", "DOI": "10.1016/j.jpeds.2007.09.007", "article-title": "Safety and efficacy of enzyme replacement therapy with agalsidase beta: an international, open-label study in pediatric patients with Fabry disease", "volume": "152", "author": "Wraith", "year": "2008", "journal-title": "J Pediatr"}, {"key": "10.1111/j.1651-2227.2010.02101.x-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "1132", "DOI": "10.1681/ASN.2008080870", "article-title": "Agalsidase alfa and kidney dysfunction in Fabry disease", "volume": "20", "author": "West", "year": "2009", "journal-title": "J Am Soc Nephrol"}, {"key": "10.1111/j.1651-2227.2010.02101.x-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "1547", "DOI": "10.1681/ASN.2006080816", "article-title": "Sustained, long-term renal stabilization after 54\u2003months of agalsidase beta therapy in patients with Fabry disease", "volume": "18", "author": "Germain", "year": "2007", "journal-title": "J Am Soc Nephrol"}, {"key": "10.1111/j.1651-2227.2010.02101.x-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "524", "DOI": "10.1161/CIRCULATIONAHA.108.794529", "article-title": "Long-term effects of enzyme replacement therapy on Fabry cardiomyopathy: evidence for a better outcome with early treatment", "volume": "119", "author": "Weidemann", "year": "2009", "journal-title": "Circulation"}, {"key": "10.1111/j.1651-2227.2010.02101.x-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "2743", "DOI": "10.1001/jama.285.21.2743", "article-title": "Enzyme replacement therapy in Fabry disease: a randomized controlled trial", "volume": "285", "author": "Schiffmann", "year": "2001", "journal-title": "JAMA"}, {"key": "10.1111/j.1651-2227.2010.02101.x-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "875", "DOI": "10.1136/adc.51.11.875", "article-title": "Estimation of glomerular filtration rate from plasma creatinine concentration in children", "volume": "51", "author": "Counahan", "year": "1976", "journal-title": "Arch Dis Child"}, {"key": "10.1111/j.1651-2227.2010.02101.x-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "358", "DOI": "10.1016/S0894-7317(89)80014-8", "article-title": "Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms", "volume": "2", "author": "Schiller", "year": "1989", "journal-title": "J Am Soc Echocardiogr"}, {"key": "10.1111/j.1651-2227.2010.02101.x-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "II19", "DOI": "10.1161/01.HYP.9.2_Pt_2.II19", "article-title": "Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization, and comparison to other methods", "volume": "9", "author": "Devereux", "year": "1987", "journal-title": "Hypertension"}, {"key": "10.1111/j.1651-2227.2010.02101.x-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "709", "DOI": "10.1016/j.echo.2009.03.003", "article-title": "Age-specific reference intervals for indexed left ventricular mass in children", "volume": "22", "author": "Khoury", "year": "2009", "journal-title": "J Am Soc Echocardiogr"}, {"key": "10.1111/j.1651-2227.2010.02101.x-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "345", "DOI": "10.1093/ndt/gfi152", "article-title": "Long-term therapy with agalsidase alfa for Fabry disease: safety and effects on renal function in a home infusion setting", "volume": "21", "author": "Schiffmann", "year": "2006", "journal-title": "Nephrol Dial Transplant"}, {"key": "10.1111/j.1651-2227.2010.02101.x-BIB22|cit22", "doi-asserted-by": "crossref", "first-page": "256", "DOI": "10.1097/GIM.0b013e3181981d82", "article-title": "Evaluation of a low dose, after a standard therapeutic dose, of agalsidase beta during enzyme replacement therapy in patients with Fabry disease", "volume": "11", "author": "Lubanda", "year": "2009", "journal-title": "Genet Med"}, {"key": "10.1111/j.1651-2227.2010.02101.x-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "1507", "DOI": "10.1093/ndt/gfp658", "article-title": "Monitoring renal function in children with Fabry disease: comparisons of measured and creatinine-based estimated glomerular filtration rate", "volume": "25", "author": "Tondel", "year": "2010", "journal-title": "Nephrol Dial Transplant"}, {"key": "10.1111/j.1651-2227.2010.02101.x-BIB24|cit24", "doi-asserted-by": "crossref", "first-page": "767", "DOI": "10.1053/j.ajkd.2007.12.032", "article-title": "Renal biopsy findings in children and adolescents with Fabry disease and minimal albuminuria", "volume": "51", "author": "Tondel", "year": "2008", "journal-title": "Am J Kidney Dis"}, {"key": "10.1111/j.1651-2227.2010.02101.x-BIB25|cit25", "doi-asserted-by": "crossref", "first-page": "365", "DOI": "10.2215/CJN.08091109", "article-title": "Assessment of renal pathology and dysfunction in children with Fabry disease", "volume": "5", "author": "Ramaswami", "year": "2010", "journal-title": "Clin J Am Soc Nephrol"}, {"key": "10.1111/j.1651-2227.2010.02101.x-BIB26|cit26", "doi-asserted-by": "crossref", "first-page": "653", "DOI": "10.12968/bjon.2008.17.10.29481", "article-title": "Home-based infusion therapy for patients with Fabry disease", "volume": "17", "author": "Cousins", "year": "2008", "journal-title": "Br J Nurs"}, {"key": "10.1111/j.1651-2227.2010.02101.x-BIB27|cit27", "doi-asserted-by": "crossref", "first-page": "330", "DOI": "10.12968/bjon.2006.15.6.20681", "article-title": "Intravenous enzyme replacement therapy: better in home or hospital?", "volume": "15", "author": "Milligan", "year": "2006", "journal-title": "Br J Nurs"}, {"key": "10.1111/j.1651-2227.2010.02101.x-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "892", "DOI": "10.12968/bjon.2010.19.14.49047", "article-title": "Intravenous enzyme replacement therapy: hospital vs home", "volume": "19", "author": "Parini", "year": "2010", "journal-title": "Br J Nurs"}, {"key": "10.1111/j.1651-2227.2010.02101.x-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "1602", "DOI": "10.1136/bjo.2009.176651", "article-title": "Fabry disease in children: correlation between ocular manifestations, genotype and systemic clinical severity", "volume": "94", "author": "Allen", "year": "2010", "journal-title": "Br J Ophthalmol"}, {"key": "10.1111/j.1651-2227.2010.02101.x-BIB30|cit30", "doi-asserted-by": "crossref", "first-page": "539", "DOI": "10.1097/01.gim.0000237866.70357.c6", "article-title": "Fabry disease: guidelines for the evaluation and management of multi-organ system involvement", "volume": "8", "author": "Eng", "year": "2006", "journal-title": "Genet Med"}], "container-title": ["Acta Paediatrica"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1651-2227.2010.02101.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 19]], "date-time": "2017-06-19T16:37:28Z", "timestamp": 1497890248000}, "score": 18.6692, "subtitle": ["Agalsidase alfa in children with Fabry disease"], "issued": {"date-parts": [[2011, 1, 12]]}, "references-count": 30, "journal-issue": {"published-print": {"date-parts": [[2011, 4]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1111/j.1651-2227.2010.02101.x", "relation": {"cites": []}, "ISSN": ["0803-5253"], "issn-type": [{"value": "0803-5253", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 24]], "date-time": "2019-11-24T05:56:03Z", "timestamp": 1574574963699}, "reference-count": 0, "publisher": "Clarivate Analytics (US)", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drugs Today"], "published-print": {"date-parts": [[2001]]}, "DOI": "10.1358/dot.2001.37.4.620591", "type": "journal-article", "created": {"date-parts": [[2015, 1, 14]], "date-time": "2015-01-14T02:11:36Z", "timestamp": 1421201496000}, "page": "257", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Gaucher disease: Genetics, diagnosis and management"], "prefix": "10.1358", "volume": "37", "author": [{"given": "M.", "family": "Levin", "sequence": "first", "affiliation": []}], "member": "71", "container-title": ["Drugs of Today"], "language": "en", "deposited": {"date-parts": [[2015, 1, 14]], "date-time": "2015-01-14T02:11:40Z", "timestamp": 1421201500000}, "score": 18.422602, "issued": {"date-parts": [[2001]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2001]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1358/dot.2001.37.4.620591", "ISSN": ["1699-3993"], "issn-type": [{"value": "1699-3993", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 29]], "date-time": "2019-11-29T22:36:35Z", "timestamp": 1575066995993}, "reference-count": 0, "publisher": "American Academy of Pediatrics (AAP)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["PEDIATRICS"], "published-print": {"date-parts": [[2005, 3, 1]]}, "DOI": "10.1542/peds.2004-1678", "type": "journal-article", "created": {"date-parts": [[2005, 2, 16]], "date-time": "2005-02-16T01:31:11Z", "timestamp": 1108517471000}, "page": "e344-e355", "source": "Crossref", "is-referenced-by-count": 127, "title": ["Pediatric Fabry Disease"], "prefix": "10.1542", "volume": "115", "author": [{"given": "M.", "family": "Ries", "sequence": "first", "affiliation": []}], "member": "417", "container-title": ["PEDIATRICS"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1542/peds.2004-1678", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T02:57:15Z", "timestamp": 1482461835000}, "score": 18.285645, "issued": {"date-parts": [[2005, 3, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2005, 3, 1]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.1542/peds.2004-1678", "ISSN": ["0031-4005", "1098-4275"], "issn-type": [{"value": "0031-4005", "type": "print"}, {"value": "1098-4275", "type": "electronic"}], "subject": ["Pediatrics, Perinatology, and Child Health"]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T07:50:35Z", "timestamp": 1574495435145}, "reference-count": 24, "publisher": "Wiley", "issue": "5", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 1069, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clin Genet"], "published-print": {"date-parts": [[2013, 5]]}, "DOI": "10.1111/j.1399-0004.2012.01947.x", "type": "journal-article", "created": {"date-parts": [[2012, 8, 6]], "date-time": "2012-08-06T18:03:26Z", "timestamp": 1344276206000}, "page": "432-438", "source": "Crossref", "is-referenced-by-count": 28, "title": ["Fabry disease in children: agalsidase-beta enzyme replacement therapy"], "prefix": "10.1111", "volume": "83", "author": [{"given": "L", "family": "Borgwardt", "sequence": "first", "affiliation": []}, {"given": "U", "family": "Feldt-Rasmussen", "sequence": "additional", "affiliation": []}, {"given": "AK", "family": "Rasmussen", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Ballegaard", "sequence": "additional", "affiliation": [{"name": "Department of Clinical Neurophysiology; Copenhagen University Hospital, Rigshospitalet; Copenhagen; Denmark"}]}, {"given": "A", "family": "Meldgaard Lund", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2012, 9, 27]]}, "reference": [{"key": "10.1111/j.1399-0004.2012.01947.x-BIB0001|cge1947-cit-0001", "doi-asserted-by": "crossref", "first-page": "65", "DOI": "10.1016/j.pharmthera.2009.01.003", "article-title": "Fabry disease", "volume": "122", "author": "Schiffmann", "year": "2009", "journal-title": "Pharmacol Ther"}, {"key": "10.1111/j.1399-0004.2012.01947.x-BIB0002|cge1947-cit-0002", "doi-asserted-by": "crossref", "first-page": "522", "DOI": "10.1007/s00431-003-1222-y", "article-title": "Enzyme replacement therapy in an adolescent with Fabry disease", "volume": "162", "author": "Illsinger", "year": "2003", "journal-title": "Eur J Pediatr"}, {"key": "10.1111/j.1399-0004.2012.01947.x-BIB0003|cge1947-cit-0003", "first-page": "595", "article-title": "Monitoring the clinical and biochemical response to enzyme replacement therapy in three children with Fabry disease", "volume": "163", "author": "Mills", "year": "2004", "journal-title": "Eur J Pediatr"}, {"key": "10.1111/j.1399-0004.2012.01947.x-BIB0004|cge1947-cit-0004", "doi-asserted-by": "crossref", "first-page": "1355", "DOI": "10.1007/s00431-009-0937-9", "article-title": "Fabry disease in children and the effects of enzyme replacement treatment", "volume": "168", "author": "Pintos-Morell", "year": "2009", "journal-title": "Eur J Pediatr"}, {"key": "10.1111/j.1399-0004.2012.01947.x-BIB0005|cge1947-cit-0005", "doi-asserted-by": "crossref", "first-page": "122", "DOI": "10.1111/j.1651-2227.2007.00029.x", "article-title": "Enzyme replacement therapy with agalsidase alfa in children with Fabry disease", "volume": "96", "author": "Ramaswami", "year": "2007", "journal-title": "Acta Paediatr"}, {"key": "10.1111/j.1399-0004.2012.01947.x-BIB0006|cge1947-cit-0006", "doi-asserted-by": "crossref", "first-page": "485", "DOI": "10.1111/j.1399-0004.2011.01671.x", "article-title": "Fabry disease in children and response to enzyme replacement therapy: results from the Fabry Outcome Survey", "volume": "81", "author": "Ramaswami", "year": "2011", "journal-title": "Clin Genet"}, {"key": "10.1111/j.1399-0004.2012.01947.x-BIB0007|cge1947-cit-0007", "doi-asserted-by": "crossref", "first-page": "924", "DOI": "10.1542/peds.2005-2895", "article-title": "Enzyme-replacement therapy with agalsidase alfa in children with Fabry disease", "volume": "118", "author": "Ries", "year": "2006", "journal-title": "Pediatrics"}, {"key": "10.1111/j.1399-0004.2012.01947.x-BIB0008|cge1947-cit-0008", "doi-asserted-by": "crossref", "first-page": "832", "DOI": "10.1016/j.jpeds.2009.11.007", "article-title": "Four-year prospective clinical trial of agalsidase alfa in children with Fabry disease", "volume": "156", "author": "Schiffmann", "year": "2010", "journal-title": "J Pediatr"}, {"key": "10.1111/j.1399-0004.2012.01947.x-BIB0009|cge1947-cit-0009", "first-page": "3388", "article-title": "Intravenous enzyme substitution therapy in children with Fabry's disease", "volume": "123", "author": "Tondel", "year": "2003", "journal-title": "Tidsskr Nor Laegeforen"}, {"key": "10.1111/j.1399-0004.2012.01947.x-BIB0010|cge1947-cit-0010", "doi-asserted-by": "crossref", "first-page": "563", "DOI": "10.1016/j.jpeds.2007.09.007", "article-title": "Safety and efficacy of enzyme replacement therapy with agalsidase-beta: an international, open-label study in pediatric patients with Fabry disease", "volume": "152", "author": "Wraith", "year": "2008", "journal-title": "J Pediatr"}, {"key": "10.1111/j.1399-0004.2012.01947.x-BIB0011|cge1947-cit-0011", "doi-asserted-by": "crossref", "first-page": "605", "DOI": "10.1111/j.1651-2227.2010.02101.x", "article-title": "Safety of agalsidase-alfa in patients with Fabry disease under 7 years", "volume": "100", "author": "Ramaswami", "year": "2011", "journal-title": "Acta Paediatr"}, {"key": "10.1111/j.1399-0004.2012.01947.x-BIB0012|cge1947-cit-0012", "first-page": "BP31", "article-title": "Guidelines for glomerular filtration rate determination in children", "volume": "28", "author": "Piepsz", "year": "2001", "journal-title": "Eur J Nucl Med"}, {"key": "10.1111/j.1399-0004.2012.01947.x-BIB0013|cge1947-cit-0013", "doi-asserted-by": "crossref", "first-page": "1746", "DOI": "10.1212/WNL.50.6.1746", "article-title": "Quantitative analysis of cerebral vasculopathy in patients with Fabry disease", "volume": "50", "author": "Crutchfield", "year": "1998", "journal-title": "Neurology"}, {"key": "10.1111/j.1399-0004.2012.01947.x-BIB0014|cge1947-cit-0014", "doi-asserted-by": "crossref", "first-page": "231", "DOI": "10.1016/j.brainresbull.2003.09.021", "article-title": "White matter lesions in Fabry disease occur in \u2018prior\u2019 selectively hypometabolic and hyperperfused brain regions", "volume": "62", "author": "Moore", "year": "2003", "journal-title": "Brain Res Bull"}, {"key": "10.1111/j.1399-0004.2012.01947.x-BIB0015|cge1947-cit-0015", "doi-asserted-by": "crossref", "first-page": "2179", "DOI": "10.2165/11318300-000000000-00000", "article-title": "Enzyme replacement therapy for Fabry disease: a systematic review of available evidence", "volume": "69", "author": "Schaefer", "year": "2009", "journal-title": "Drugs"}, {"key": "10.1111/j.1399-0004.2012.01947.x-BIB0016|cge1947-cit-0016", "doi-asserted-by": "crossref", "first-page": "365", "DOI": "10.1073/pnas.97.1.365", "article-title": "Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease", "volume": "97", "author": "Schiffmann", "year": "2000", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10.1111/j.1399-0004.2012.01947.x-BIB0017|cge1947-cit-0017", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1016/j.pain.2009.06.032", "article-title": "Functional and structural nerve fiber findings in heterozygote patients with Fabry disease", "volume": "145", "author": "Torvin", "year": "2009", "journal-title": "Pain"}, {"key": "10.1111/j.1399-0004.2012.01947.x-BIB0018|cge1947-cit-0018", "doi-asserted-by": "crossref", "first-page": "360", "DOI": "10.2215/CJN.06090809", "article-title": "Biomarkers of Fabry disease nephropathy", "volume": "5", "author": "Schiffmann", "year": "2010", "journal-title": "Clin J Am Soc Nephrol"}, {"key": "10.1111/j.1399-0004.2012.01947.x-BIB0019|cge1947-cit-0019", "doi-asserted-by": "crossref", "first-page": "463", "DOI": "10.1111/j.1651-2227.2008.00700.x", "article-title": "Cardiac manifestations of Anderson-Fabry disease in children and adolescents", "volume": "97", "author": "Kampmann", "year": "2008", "journal-title": "Acta Paediatr"}, {"key": "10.1111/j.1399-0004.2012.01947.x-BIB0020|cge1947-cit-0020", "doi-asserted-by": "crossref", "first-page": "767", "DOI": "10.1053/j.ajkd.2007.12.032", "article-title": "Renal biopsy findings in children and adolescents with Fabry disease and minimal albuminuria", "volume": "51", "author": "Tondel", "year": "2008", "journal-title": "Am J Kidney Dis"}, {"issue": "Suppl. 2", "key": "10.1111/j.1399-0004.2012.01947.x-BIB0021|cge1947-cit-0021", "doi-asserted-by": "crossref", "first-page": "S139", "DOI": "10.1097/01.ASN.0000016683.73778.78", "article-title": "Natural history and treatment of renal involvement in Fabry disease", "volume": "13", "author": "Branton", "year": "2002", "journal-title": "J Am Soc Nephrol"}, {"key": "10.1111/j.1399-0004.2012.01947.x-BIB0022|cge1947-cit-0022", "doi-asserted-by": "crossref", "first-page": "70", "DOI": "10.1016/j.bbadis.2010.09.007", "article-title": "Reduction of elevated plasma globotriaosylsphingosine in patients with classic Fabry disease following enzyme replacement therapy", "volume": "1812", "author": "Breemen", "year": "2011", "journal-title": "Biochim Biophys Acta"}, {"key": "10.1111/j.1399-0004.2012.01947.x-BIB0023|cge1947-cit-0023", "doi-asserted-by": "crossref", "first-page": "e344", "DOI": "10.1542/peds.2004-1678", "article-title": "Pediatric Fabry disease", "volume": "115", "author": "Ries", "year": "2005", "journal-title": "Pediatrics"}, {"key": "10.1111/j.1399-0004.2012.01947.x-BIB0024|cge1947-cit-0024", "doi-asserted-by": "crossref", "first-page": "1547", "DOI": "10.1681/ASN.2006080816", "article-title": "Sustained, long-term renal stabilization after 54\u2009months of agalsidase-beta therapy in patients with Fabry disease", "volume": "18", "author": "Germain", "year": "2007", "journal-title": "J Am Soc Nephrol"}], "container-title": ["Clinical Genetics"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1399-0004.2012.01947.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 7, 2]], "date-time": "2019-07-02T15:33:04Z", "timestamp": 1562081584000}, "score": 18.267109, "subtitle": ["Fabry disease in children"], "issued": {"date-parts": [[2012, 9, 27]]}, "references-count": 24, "journal-issue": {"published-print": {"date-parts": [[2013, 5]]}, "issue": "5"}, "URL": "http://dx.doi.org/10.1111/j.1399-0004.2012.01947.x", "relation": {"cites": []}, "ISSN": ["0009-9163"], "issn-type": [{"value": "0009-9163", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T17:17:14Z", "timestamp": 1574270234608}, "reference-count": 28, "publisher": "BMJ", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Archives of Disease in Childhood"], "published-print": {"date-parts": [[1984, 5, 1]]}, "DOI": "10.1136/adc.59.5.397", "type": "journal-article", "created": {"date-parts": [[2008, 12, 22]], "date-time": "2008-12-22T21:51:33Z", "timestamp": 1229982693000}, "page": "397-400", "source": "Crossref", "is-referenced-by-count": 48, "title": ["Haemolytic uraemic syndrome."], "prefix": "10.1136", "volume": "59", "author": [{"given": "M", "family": "Levin", "sequence": "first", "affiliation": []}, {"given": "J M", "family": "Barratt", "sequence": "additional", "affiliation": []}], "member": "239", "reference": [{"key": "ref_1", "first-page": "35", "article-title": "Haemolytic uraemic syndrome: current concepts and management", "volume": "29", "author": "Fong, J.S.C.; de Chadarevian, J.P.; Kaplan, B.S.", "year": "1982", "unstructured": "Fong JSC, de Chadarevian JP, Kaplan BS. Haemolytic uraemic syndrome: current concepts and management. Pediatr Clin North Am 1982;29:B35-56.", "journal-title": "Pediatr Clin North Am"}, {"key": "ref_2", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1136/adc.58.2.101", "article-title": "Haemolytic uraemic syndrome in childhood: analysis of prognostic features", "volume": "58", "author": "Trompeter, R.S.; Schwartz, R.; Chantler, C.", "year": "1983", "unstructured": "Trompeter RS, Schwartz R, Chantler C, et al. Haemolytic uraemic syndrome in childhood: analysis of prognostic features. Arch Dis Child 1983;58:101-5.", "journal-title": "Arch Dis Child"}, {"key": "ref_3", "doi-asserted-by": "crossref", "first-page": "1090", "DOI": "10.1056/NEJM197505222922102", "article-title": "Haemolytic uraemic syndrome in families", "volume": "292", "author": "Kaplan, B.S.; Chesney, R.W.; Drummond, K.N.", "year": "1975", "unstructured": "Kaplan BS, Chesney RW, Drummond KN. Haemolytic uraemic syndrome in families. N Engl J Med 1975;292:1090-3.", "journal-title": "N Engl J Med"}, {"key": "ref_4", "doi-asserted-by": "crossref", "first-page": "927", "DOI": "10.1056/NEJM197804272981702", "article-title": "Haemolytic-uracmic syndrome after shigellosis: relation to endotoxemia and circulating immune complexes", "volume": "298", "author": "Koster, F.; Levin, J.; Walker, L.", "year": "1978", "unstructured": "Koster F, Levin J, Walker L, et al. Haemolytic-uracmic syndrome after shigellosis: relation to endotoxemia and circulating immune complexes. N Engl J Med 1978;298:927-33.", "journal-title": "N Engl J Med"}, {"key": "ref_5", "first-page": "359", "article-title": "Haemolytic-uraemic syndrome associated with neuraminidase producing microorganisms: treatment by exchange transfusion", "volume": "35", "author": "Seger, R.; Joller, P.; Baerlocher, K.", "year": "1980", "unstructured": "Seger R, Joller P, Baerlocher K, et al. Haemolytic-uraemic syndrome associated with neuraminidase producing microorganisms: treatment by exchange transfusion. Helv Paediatr Acta 1980;35:359-67.", "journal-title": "Helv Paediatr Acta"}, {"key": "ref_6", "doi-asserted-by": "crossref", "first-page": "1024", "DOI": "10.1016/S0140-6736(77)92915-4", "article-title": "Thomsen Friedenreich antigen in haemolytic uraemic syndrome", "volume": "ii:", "author": "Klein, P.J.; Bulla, M.; Newman, R.A.", "year": "1977", "unstructured": "Klein PJ, Bulla M, Newman RA, et al. Thomsen Friedenreich antigen in haemolytic uraemic syndrome. Lancet 1977;ii:1024-5.", "journal-title": "Lancet"}, {"key": "ref_7", "first-page": "619", "article-title": "Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin producing Escherichia coli in stools", "volume": "i:", "author": "Karmali, M.A.; Steele, B.T.; Petric, M.; Lim, C.", "year": "1983", "unstructured": "Karmali MA, Steele BT, Petric M, Lim C. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin producing Escherichia coli in stools. Lancet 1983;i:619-20.", "journal-title": "Lancet"}, {"key": "ref_8", "first-page": "99", "article-title": "Prognosis of the haemolytic-uraemic syndrome in children", "volume-title": "Advances in nephrology", "author": "Habib, R.; Levy, M.; Gagnadoux, M.F.; Broyer, M.", "year": "1982", "unstructured": "Habib R, Levy M, Gagnadoux MF, Broyer M. Prognosis of the haemolytic-uraemic syndrome in children. In: Morton, Maxwell, eds. Advances in nephrology. Chicago, London: Year Book Medical Publishers, 1982:99-128."}, {"key": "ref_9", "author": "Kanfer, A.; Morel-Maroger, L.; Solez, K.; Sraer, J.D.; Richet, G.", "first-page": "399", "year": "1980", "unstructured": "Kanfer A, Morel-Maroger L, Solez K, Sraer JD, Richet G. In: Remuzzi G, Mecca G, De Gaetano G, eds. The value of renal biopsy in hemolytic uremic syndrome in adults. New York: Raven Press, 1980:399-406.", "volume-title": "The value of renal biopsy in hemolytic uremic syndrome in adults"}, {"issue": "6", "key": "ref_10", "first-page": "162", "article-title": "The haemolytic-uraemic syndrome", "volume": "1969", "author": "Brain, M.C.", "unstructured": "Brain MC. The haemolytic-uraemic syndrome. Semin Hematol 1969;6:162-80.", "journal-title": "Semin Hematol"}, {"key": "ref_11", "doi-asserted-by": "crossref", "first-page": "1111", "DOI": "10.1056/NEJM197411212912105", "article-title": "A kinetic evaluation of hemostasis in renal disease", "volume": "291", "author": "George, C.R.P.; Slichter, S.J.; Quadracci, L.J.; Striker, G.E.; Harker, L.A.", "year": "1974", "unstructured": "George CRP, Slichter SJ, Quadracci LJ, Striker GE, Harker LA. A kinetic evaluation of hemostasis in renal disease. N EngI J Med 1974;291:1111-5.", "journal-title": "N EngI J Med"}, {"key": "ref_12", "first-page": "890", "article-title": "Platelets, endothelium and renal disease (editorial)", "volume": "ii:", "author": "Anonymous", "year": "1979", "unstructured": "Anonymous. Platelets, endothelium and renal disease (editorial). Lancet 1979;ii:890-2.", "journal-title": "Lancet"}, {"key": "ref_13", "doi-asserted-by": "crossref", "first-page": "739", "DOI": "10.1016/S0022-3476(73)80364-6", "article-title": "Platelet, erythrocyte and fibrinogen kinetics in the hemolytic uremic syndrome of infancy", "volume": "83", "author": "Katz, J.; Krawitz, S.; Sacks, P.V.", "year": "1973", "unstructured": "Katz J, Krawitz S, Sacks PV, et al. Platelet, erythrocyte and fibrinogen kinetics in the hemolytic uremic syndrome of infancy. J Pediatr 1973;83:739-48.", "journal-title": "J Pediatr"}, {"key": "ref_14", "first-page": "564", "article-title": "Impairment of platelet aggregation in hemolytic uremic syndrome: evidence for platelet 'exhaustion'. Blood", "volume": "60", "author": "Fong, J.S.C.; Kaplan, B.S.", "year": "1982", "unstructured": "Fong JSC, Kaplan BS. Impairment of platelet aggregation in hemolytic uremic syndrome: evidence for platelet 'exhaustion'. Blood 1982;60:564-70."}, {"key": "ref_15", "first-page": "305", "article-title": "Prostacyclin: its biosynthesis, actions and clinical potential. Phil Trans R Soc London fBioll", "volume": "294", "author": "Moncada, S.; Vane, JR", "year": "1981", "unstructured": "Moncada S, Vane JR. Prostacyclin: its biosynthesis, actions and clinical potential. Phil Trans R Soc London fBioll 1981;294: 305-29."}, {"key": "ref_16", "first-page": "239", "article-title": "Prostacyclin, platelet aggregation and thrombosis", "volume-title": "Platelets: a multi-disciplinary approach", "author": "Moncada, S.; Vane, JR", "year": "1978", "unstructured": "Moncada S, Vane JR. Prostacyclin, platelet aggregation and thrombosis. In: De Gaetano G, Garattini S, eds. Platelets: a multi-disciplinary approach. New York: Raven Press, 1978: 239-58."}, {"key": "ref_17", "doi-asserted-by": "crossref", "first-page": "871", "DOI": "10.1016/S0140-6736(78)91573-8", "article-title": "Haemolytic-uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity?", "volume": "ii:", "author": "Remuzzi, G.; Marchesi, D.; Mecca, G.", "year": "1978", "unstructured": "Remuzzi G, Marchesi D, Mecca G, et al. Haemolytic-uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity? Lancet 1978;ii:871-2.", "journal-title": "Lancet"}, {"key": "ref_18", "doi-asserted-by": "crossref", "first-page": "656", "DOI": "10.1016/S0140-6736(80)91153-8", "article-title": "Prostacyclin generation by cultured endothelial cells in haemolytic-uraemic syndrome", "volume": "i:", "author": "Remuzzi, G.; Mecca, G.; Livio, M.", "year": "1980", "unstructured": "Remuzzi G, Mecca G, Livio M, et al. Prostacyclin generation by cultured endothelial cells in haemolytic-uraemic syndrome. Lancet 1980;i:656-7.", "journal-title": "Lancet"}, {"key": "ref_19", "doi-asserted-by": "crossref", "first-page": "1304", "DOI": "10.1136/bmj.285.6351.1304", "article-title": "Haemolytic uraemic syndrome: therapeutic effect of plasma infusion", "volume": "285", "author": "Misiani, R.; Appiani, A.C.; Edeforti, A.", "year": "1982", "unstructured": "Misiani R, Appiani AC, Edeforti A, et al. Haemolytic uraemic syndrome: therapeutic effect of plasma infusion. Br Med J 1982;285:1304-6.", "journal-title": "Br Med J"}, {"key": "ref_20", "first-page": "413", "article-title": "Plasmapheresis in the treatment of thrombotic thrombocytopenic purpura", "volume": "50", "author": "Bukowski, R.M.; King, J.W.; Hewlett, J.S.", "year": "1977", "unstructured": "Bukowski RM, King JW, Hewlett JS. Plasmapheresis in the treatment of thrombotic thrombocytopenic purpura. Blood 1977;50:413-7.", "journal-title": "Blood"}, {"key": "ref_21", "doi-asserted-by": "crossref", "first-page": "703", "DOI": "10.1136/adc.58.9.703", "article-title": "Inhibitor of prostacyclin production in sporadic haemolytic uraemic syndrome", "volume": "58", "author": "Levin, M.; Elkon, K.B.; Buckle, A.M.", "year": "1983", "unstructured": "Levin M, Elkon KB, Buckle AM, et al. Inhibitor of prostacyclin production in sporadic haemolytic uraemic syndrome. Arch Dis Child 1983;58:703-8.", "journal-title": "Arch Dis Child"}, {"key": "ref_22", "first-page": "120", "article-title": "Abnormal platelet and vascular prostaglandin synthcsis in an infant with the hemolytic uremic syndrome", "volume": "71", "author": "Stuart, M.J.; Spitzer, R.E.; Coppe, D.", "year": "1983", "unstructured": "Stuart MJ, Spitzer RE, Coppe D. Abnormal platelet and vascular prostaglandin synthcsis in an infant with the hemolytic uremic syndrome. Pediatrics 1983;71:120-4.", "journal-title": "Pediatrics"}, {"key": "ref_23", "first-page": "267", "article-title": "Accelcrated prostacyclin degradation in thromhotic thrombocytopenic purpura", "volume": "Jii:", "author": "Chen, Y.C.; Wu, Hall E.R.McLeod B.; K.K.", "year": "1981", "unstructured": "Chen YC, Hall ER. McLeod B. Wu KK. Accelcrated prostacyclin degradation in thromhotic thrombocytopenic purpura. Lancet 1981 Jii:267-9.", "journal-title": "Lancet"}, {"key": "ref_24", "first-page": "43", "article-title": "Ahnormal prostacyclin metabolism in the hemolytic uremic syndrome: equivocal effects of prostacylin infusions", "volume": "18", "author": "Defreyn, G.; Proesmans, W.; Vermylen, Machin S.J.I.Lemmens F.; J.", "year": "1982", "unstructured": "Defreyn G, Proesmans W, Machin SJI Lemmens F. Vermylen J. Ahnormal prostacyclin metabolism in the hemolytic uremic syndrome: equivocal effects of prostacylin infusions. Clin Nephrol 1982;18:43-9.", "journal-title": "Clin Nephrol"}, {"key": "ref_25", "first-page": "333", "article-title": "Presence of a platelet aggregating factor in the plasma of patients with thrombotic thrombocytopenic purpura (TTP) and its inhibition by normal plasma", "volume": "53", "author": "Lian, E.C.Y.; Harkness, D.R.; Byrnes, J.J.; Wallach, H.; Nunez, R.", "year": "1979", "unstructured": "Lian ECY, Harkness DR, Byrnes JJ, Wallach H, Nunez R. Presence of a platelet aggregating factor in the plasma of patients with thrombotic thrombocytopenic purpura (TTP) and its inhibition by normal plasma. Blood 1979;53:333-8.", "journal-title": "Blood"}, {"key": "ref_26", "doi-asserted-by": "crossref", "first-page": "1432", "DOI": "10.1056/NEJM198212023072306", "article-title": "Unusually large plasma factor Vil von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura", "volume": "307", "author": "Moake, J.L.; Rudy, C.K.; Troll, J.H.", "year": "1982", "unstructured": "Moake JL, Rudy CK, Troll JH. et al. Unusually large plasma factor Vil von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Enzgl J Med 1982;307:1432-5.", "journal-title": "N Enzgl J Med"}, {"key": "ref_27", "first-page": "\"373", "article-title": "Demonstration of immune complexes in thrombotic thrombocytopenic purpura and effect of exchange transfusion", "volume": "24", "author": "Sacher, R.A.; Phillips, T.M.; Shashaty, G.G.; Lewis, Jacobscn R.J.Rath C.E.; M.G.", "year": "1980", "unstructured": "Sacher RA, Phillips TM, Shashaty GG, Jacobscn RJ. Rath CE. Lewis MG. Demonstration of immune complexes in thrombotic thrombocytopenic purpura and effect of exchange transfusion. Scand J Hae,natol 1980;24:373-80. x Burns ER, Zucker-Franklin D. Pathologic effects of plasma from patients with thrombotic thrombocytopenic purpura on platelets and cultured vascular endothelial cells. Blood 1982;60:1030-7.", "journal-title": "Scand J Hae, natol; Pathologic effects of plasma from patients with thrombotic thrombocytopenic purpura on platelets and cultured vascular endothelial cells"}, {"key": "ref_28", "first-page": "99", "article-title": "Interactions of platelets. leucocytes and endothelium with bacterial endotoxins: possible relevance in kidney disorders", "volume-title": "prostaglandins and renal disease", "author": "Semaro, N.", "year": "1980", "unstructured": "Semaro N. Interactions of platelets. leucocytes and endothelium with bacterial endotoxins: possible relevance in kidney disorders. In: Remuzzi G, Mecca G, Dc Gaetano G, eds. Hemostasis, prostaglandins and renal disease. New York: Raven Press, 1980:99-116."}], "container-title": ["Archives of Disease in Childhood"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1136/adc.59.5.397", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 2]], "date-time": "2019-02-02T02:45:28Z", "timestamp": 1549075528000}, "score": 18.14937, "issued": {"date-parts": [[1984, 5, 1]]}, "references-count": 28, "journal-issue": {"published-print": {"date-parts": [[1984, 5, 1]]}, "issue": "5"}, "URL": "http://dx.doi.org/10.1136/adc.59.5.397", "relation": {"cites": []}, "ISSN": ["0003-9888", "1468-2044"], "issn-type": [{"value": "0003-9888", "type": "print"}, {"value": "1468-2044", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T19:43:45Z", "timestamp": 1574451825330}, "publisher-location": "Dordrecht", "reference-count": 65, "publisher": "Springer Netherlands", "isbn-type": [{"value": "9789048190324", "type": "print"}, {"value": "9789048190331", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2010]]}, "DOI": "10.1007/978-90-481-9033-1_15", "type": "book-chapter", "created": {"date-parts": [[2010, 7, 31]], "date-time": "2010-07-31T18:26:49Z", "timestamp": 1280600809000}, "page": "275-292", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Histopathology of Skin in Fabry Disease"], "prefix": "10.1007", "author": [{"given": "Carmen", "family": "Navarro", "sequence": "first", "affiliation": []}, {"given": "Susana", "family": "Teijeira", "sequence": "additional", "affiliation": []}, {"given": "Saida", "family": "Ortolano", "sequence": "additional", "affiliation": []}, {"given": "Jose M.", "family": "Fernandez", "sequence": "additional", "affiliation": []}, {"given": "Beatriz San", "family": "Millan", "sequence": "additional", "affiliation": []}, {"given": "Carmen", "family": "Fachal", "sequence": "additional", "affiliation": []}, {"given": "Francisco", "family": "Allegue", "sequence": "additional", "affiliation": []}, {"given": "Soraya", "family": "Barrera", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2010, 7, 10]]}, "reference": [{"key": "15_CR1", "first-page": "3733", "volume-title": "The metabolic and molecular basis of inherited disease", "author": "RJ Desnick", "year": "2001", "unstructured": "Desnick RJ, Ioannou YA, Eng CM (2001) Alpha-galactosidase A deficiency: Fabry disease. In: Scriver C, Beaudet A, Sly W, Valle D, Kinzler DE, Volgestein B (eds) The metabolic and molecular basis of inherited disease, 8th edn. McGraw-Hill Inc, New York, pp 3733\u20133774", "edition": "8"}, {"key": "15_CR2", "doi-asserted-by": "publisher", "first-page": "331", "DOI": "10.1111/j.1365-2133.2007.08002.x", "volume": "157", "author": "CH Orteu", "year": "2007", "unstructured": "Orteu CH, Jansen T, Lidove O et al (2007) Fabry disease and the skin: data from FOS, the Fabry outcome survey. Br J Dermatol 157:331\u2013337", "journal-title": "Br J Dermatol"}, {"key": "15_CR3", "doi-asserted-by": "publisher", "first-page": "767", "DOI": "10.1007/s00431-003-1299-3", "volume": "162", "author": "M Ries", "year": "2003", "unstructured": "Ries M, Ramaswami U, Parini R et al (2003) The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents. Eur J Pediatr 162:767\u2013772", "journal-title": "Eur J Pediatr"}, {"key": "15_CR4", "doi-asserted-by": "publisher", "first-page": "1440", "DOI": "10.1001/archderm.140.12.1440", "volume": "140", "author": "M Larralde", "year": "2004", "unstructured": "Larralde M, Boggio P, Amartino H, Chamoles N (2004) Fabry disease: a study of 6 hemizygous men and 5 heterozygous women with emphasis on dermatologic manifestations. Arch Dermatol 140:1440\u20131446", "journal-title": "Arch Dermatol"}, {"key": "15_CR5", "doi-asserted-by": "publisher", "first-page": "189", "DOI": "10.2165/00128071-200304030-00005", "volume": "4", "author": "M Mohrenschlager", "year": "2003", "unstructured": "Mohrenschlager M, Braun-Falco M, Ring J, Abeck D (2003) Fabry disease: recognition and management of cutaneous manifestations. Am J Clin Dermatol 4:189\u2013196", "journal-title": "Am J Clin Dermatol"}, {"key": "15_CR6", "doi-asserted-by": "publisher", "first-page": "57", "DOI": "10.1157/13063178", "volume": "123", "author": "MA Barba Romero", "year": "2004", "unstructured": "Barba Romero MA, Garcia de Lorenzo y Mateos A, Groupo Espanol de Estudio de FOS (2004) Fabry\u2019s disease in Spain. Study of 24 cases. Med Clin (Barc) 123:57\u201360", "journal-title": "Med Clin (Barc)"}, {"key": "15_CR7", "doi-asserted-by": "publisher", "first-page": "652", "DOI": "10.1111/j.1346-8138.2006.00154_1.x", "volume": "33", "author": "T Jansen", "year": "2006", "unstructured": "Jansen T, Graue N, Dissemond J, Hillen U, Hentschke M, Grabbe S (2006) Telangiectasias on the neck as a presenting cutaneous sign of Fabry disease. J Dermatol 33:652\u2013654", "journal-title": "J Dermatol"}, {"key": "15_CR8", "doi-asserted-by": "publisher", "first-page": "594", "DOI": "10.1111/j.1365-2133.1997.tb02149.x", "volume": "136", "author": "C Fleming", "year": "1997", "unstructured": "Fleming C, Rennie A, Fallowfield M, McHenry PM (1997) Cutaneous manifestations of fucosidosis. Br J Dermatol 136:594\u2013597", "journal-title": "Br J Dermatol"}, {"key": "15_CR9", "doi-asserted-by": "publisher", "first-page": "506", "DOI": "10.1111/j.0303-6987.2005.00366.x", "volume": "32", "author": "J Kanitakis", "year": "2005", "unstructured": "Kanitakis J, Allombert C, Doebelin B et al (2005) Fucosidosis with angiokeratoma. Immunohistochemical & electronmicroscopic study of a new case and literature review. J Cutan Pathol 32:506\u2013511", "journal-title": "J Cutan Pathol"}, {"key": "15_CR10", "doi-asserted-by": "publisher", "first-page": "1219", "DOI": "10.1001/archderm.132.10.1219", "volume": "132", "author": "M Rodriguez-Serna", "year": "1996", "unstructured": "Rodriguez-Serna M, Botella-Estrada R, Chabas A et al (1996) Angiokeratoma corporis diffusum associated with beta-mannosidase deficiency. Arch Dermatol 132:1219\u20131222", "journal-title": "Arch Dermatol"}, {"key": "15_CR11", "doi-asserted-by": "publisher", "first-page": "407", "DOI": "10.1016/j.jaad.2007.01.037", "volume": "57", "author": "V Molho-Pessach", "year": "2007", "unstructured": "Molho-Pessach V, Bargal R, Abramowitz Y et al (2007) Angiokeratoma corporis diffusum in human beta-mannosidosis: report of a new case and a novel mutation. J Am Acad Dermatol 57:407\u2013412", "journal-title": "J Am Acad Dermatol"}, {"key": "15_CR12", "doi-asserted-by": "publisher", "first-page": "52", "DOI": "10.1159/000017956", "volume": "197", "author": "Y Kawachi", "year": "1998", "unstructured": "Kawachi Y, Matsu-ura K, Sakuraba H, Otsuka F (1998) Angiokeratoma corporis diffusum associated with galactosialidosis. Dermatology 197:52\u201354", "journal-title": "Dermatology"}, {"key": "15_CR13", "doi-asserted-by": "publisher", "first-page": "615", "DOI": "10.1001/archderm.142.5.615", "volume": "142", "author": "B Kelly", "year": "2006", "unstructured": "Kelly B, Kelly E (2006) Angiokeratoma corporis diffusum in a patient with no recognizable enzyme abnormalities. Arch Dermatol 142:615\u2013618", "journal-title": "Arch Dermatol"}, {"key": "15_CR14", "author": "C Navarro", "year": "1995", "unstructured": "Navarro C (1995) Estudio ultraestructural de la piel. Su contribuci\u00f3n al diagn\u00f3stico de las enfermedades metab\u00f3licas que afectan al Sistema Nervioso Central. University of Barcelona, Barcelona", "volume-title": "Estudio ultraestructural de la piel. Su contribuci\u00f3n al diagn\u00f3stico de las enfermedades metab\u00f3licas que afectan al Sistema Nervioso Central"}, {"key": "15_CR15", "author": "CM Groote de", "year": "1998", "unstructured": "de Groote CM (1998) Het Electronmicroscopisch Onderzoek van Huidbiopten als Metabole Aandoeningen van het. Zenuwestel. Born-Bunge Stichting, University of Antwerpen, Antwerpen", "volume-title": "Het Electronmicroscopisch Onderzoek van Huidbiopten als Metabole Aandoeningen van het. Zenuwestel"}, {"key": "15_CR16", "doi-asserted-by": "publisher", "first-page": "1163", "DOI": "10.1056/NEJM196705252762101", "volume": "276", "author": "RO Brady", "year": "1967", "unstructured": "Brady RO, Gal AE, Bradley RM et al (1967) Enzymatic defect in Fabry\u2019s disease. Ceramidetrihexosidase deficiency. N Engl J Med 276:1163\u20131167", "journal-title": "N Engl J Med"}, {"key": "15_CR17", "doi-asserted-by": "publisher", "first-page": "281", "DOI": "10.1002/(SICI)1097-4652(199808)176:2<281::AID-JCP6>3.0.CO;2-K", "volume": "176", "author": "AA Khine", "year": "1998", "unstructured": "Khine AA, Firtel M, Lingwood CA (1998) CD77-dependent retrograde transport of CD19 to the nuclear membrane: functional relationship between CD77 and CD19 during germinal center B-cell apoptosis. J Cell Physiol 176:281\u2013292", "journal-title": "J Cell Physiol"}, {"key": "15_CR18", "doi-asserted-by": "publisher", "first-page": "45200", "DOI": "10.1074/jbc.M303868200", "volume": "278", "author": "C Tetaud", "year": "2003", "unstructured": "Tetaud C, Falguieres T, Carlier K et al (2003) Two distinct Gb3/CD77 signaling pathways leading to apoptosis are triggered by anti-Gb3/CD77 mAb and verotoxin-1. J Biol Chem 278:45200\u201345208", "journal-title": "J Biol Chem"}, {"key": "15_CR19", "doi-asserted-by": "publisher", "first-page": "179", "DOI": "10.1016/0022-510X(84)90082-0", "volume": "65", "author": "C Ceuterick", "year": "1984", "unstructured": "Ceuterick C, Martin JJ (1984) Diagnostic role of skin or conjunctival biopsies in neurological disorders. An update. J Neurol Sci 65:179\u2013191", "journal-title": "J Neurol Sci"}, {"key": "15_CR20", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.1038/jid.1965.22", "volume": "44", "author": "K Hashimoto", "year": "1965", "unstructured": "Hashimoto K, Gross BG, Lever WF (1965) Angiokeratoma Corporis Diffusum (Fabry). Histochemical and Electron Microscopic Studies of the Skin. J Invest Dermatol 44:119\u2013128", "journal-title": "J Invest Dermatol"}, {"key": "15_CR21", "doi-asserted-by": "publisher", "first-page": "1618", "DOI": "10.1001/archderm.1987.01660360046011", "volume": "123", "author": "S Carpenter", "year": "1987", "unstructured": "Carpenter S (1987) Skin biopsy for diagnosis of hereditary neurologic metabolic disease. Arch Dermatol 123:1618\u20131621", "journal-title": "Arch Dermatol"}, {"key": "15_CR22", "doi-asserted-by": "publisher", "first-page": "435", "DOI": "10.1016/S0387-7604(99)00061-3", "volume": "21", "author": "HH Goebel", "year": "1999", "unstructured": "Goebel HH (1999) Extracerebral biopsies in neurodegenerative diseases of childhood. Brain Dev 21:435\u2013443", "journal-title": "Brain Dev"}, {"key": "15_CR23", "doi-asserted-by": "publisher", "first-page": "649", "DOI": "10.1053/hupa.2001.24995", "volume": "32", "author": "CM Abramovich", "year": "2001", "unstructured": "Abramovich CM, Prayson RA, McMahon JT, Cohen BH (2001) Ultrastructural examination of the axillary skin biopsy in the diagnosis of metabolic diseases. Hum Pathol 32:649\u2013655", "journal-title": "Hum Pathol"}, {"key": "15_CR24", "doi-asserted-by": "publisher", "first-page": "1667", "DOI": "10.1001/archderm.1987.01660360095019", "volume": "123", "author": "GA Newton", "year": "1987", "unstructured": "Newton GA, Sanchez RL, Swedo J, Smith EB (1987) Lafora\u2019s disease. The role of skin biopsy. Arch Dermatol 123:1667\u20131669", "journal-title": "Arch Dermatol"}, {"key": "15_CR25", "doi-asserted-by": "publisher", "first-page": "121", "DOI": "10.1111/j.1750-3639.1998.tb00140.x", "volume": "8", "author": "C Ceuterick-de Groote", "year": "1998", "unstructured": "Ceuterick-de Groote C, Martin JJ (1998) Extracerebral biopsy in lysosomal and peroxisomal disorders. Ultrastructural findings. Brain Pathol 8:121\u2013132", "journal-title": "Brain Pathol"}, {"key": "15_CR26", "doi-asserted-by": "publisher", "first-page": "489", "DOI": "10.1080/01913120500520986", "volume": "30", "author": "J Alroy", "year": "2006", "unstructured": "Alroy J, Ucci AA (2006) Skin biopsy: a useful tool in the diagnosis of lysosomal storage diseases. Ultrastruct Pathol 30:489\u2013503", "journal-title": "Ultrastruct Pathol"}, {"key": "15_CR27", "doi-asserted-by": "publisher", "first-page": "823", "DOI": "10.1007/s00428-007-0468-6", "volume": "451", "author": "H Askari", "year": "2007", "unstructured": "Askari H, Kaneski CR, Semino-Mora C et al (2007) Cellular and tissue localization of globotriaosylceramide in Fabry disease. Virchows Arch 451:823\u2013834", "journal-title": "Virchows Arch"}, {"key": "15_CR28", "doi-asserted-by": "publisher", "first-page": "672", "DOI": "10.4103/0378-6323.45129", "volume": "74", "author": "PR Malur", "year": "2008", "unstructured": "Malur PR, Davanageri RS, Bannur HB, Suranagi VV (2008) Lafora\u2019s disease diagnosed on axillary skin biopsy in 3 patients. Indian J Dermatol Venereol Leprol 74:672\u2013673", "journal-title": "Indian J Dermatol Venereol Leprol"}, {"key": "15_CR29", "doi-asserted-by": "publisher", "first-page": "81", "DOI": "10.1247/csf.19.81", "volume": "19", "author": "M Kotani", "year": "1994", "unstructured": "Kotani M, Hosoya H, Kubo H et al (1994) Evidence for direct binding of intracellularly distributed ganglioside GM2 to isolated vimentin intermediate filaments in normal and Tay-Sachs disease human fibroblasts. Cell Struct Funct 19:81\u201387", "journal-title": "Cell Struct Funct"}, {"key": "15_CR30", "doi-asserted-by": "publisher", "first-page": "544", "DOI": "10.1111/j.1365-2133.2005.06732.x", "volume": "153", "author": "T Kanekura", "year": "2005", "unstructured": "Kanekura T, Fukushige T, Kanda A et al (2005) Immunoelectron-microscopic detection of globotriaosylceramide accumulated in the skin of patients with Fabry disease. Br J Dermatol 153:544\u2013548", "journal-title": "Br J Dermatol"}, {"key": "15_CR31", "doi-asserted-by": "publisher", "first-page": "689", "DOI": "10.1111/j.1442-9071.2006.01318.x", "volume": "34", "author": "PA Rozenfeld", "year": "2006", "unstructured": "Rozenfeld PA, Croxatto O, Ebner R, Fossati CA (2006) Immunofluorescence detection of globotriaosylceramide deposits in conjunctival biopsies of Fabry disease patients. Clin Exp Ophthalmol 34:689\u2013694", "journal-title": "Clin Exp Ophthalmol"}, {"key": "15_CR32", "doi-asserted-by": "publisher", "first-page": "184", "DOI": "10.1016/0022-510X(93)90223-L", "volume": "115", "author": "WR Kennedy", "year": "1993", "unstructured": "Kennedy WR, Wendelschafer-Crabb G (1993) The innervation of human epidermis. J Neurol Sci 115:184\u2013190", "journal-title": "J Neurol Sci"}, {"key": "15_CR33", "doi-asserted-by": "publisher", "first-page": "1848", "DOI": "10.1212/WNL.45.10.1848", "volume": "45", "author": "BG McCarthy", "year": "1995", "unstructured": "McCarthy BG, Hsieh ST, Stocks A et al (1995) Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology 45:1848\u20131855", "journal-title": "Neurology"}, {"key": "15_CR34", "doi-asserted-by": "publisher", "first-page": "762", "DOI": "10.1136/jnnp.65.5.762", "volume": "65", "author": "G Lauria", "year": "1998", "unstructured": "Lauria G, McArthur JC, Hauer PE, Griffin JW, Cornblath DR (1998) Neuropathological alterations in diabetic truncal neuropathy: evaluation by skin biopsy. J. Neurol. Neurosurg. Psychiatry 65:762\u2013766", "journal-title": "J. Neurol. Neurosurg. Psychiatry"}, {"key": "15_CR35", "first-page": "25", "volume-title": "Histology for pathologists", "author": "CD Urmacher", "year": "1997", "unstructured": "Urmacher CD (1997) Normal skin. In: Sternberg SS (ed) Histology for pathologists, 2nd edn. Lippincott-Raven, Philadelphia, pp 25\u201345", "edition": "2"}, {"key": "15_CR36", "doi-asserted-by": "crossref", "first-page": "208", "DOI": "10.1038/jid.1968.28", "volume": "50", "author": "RW Sagebiel", "year": "1968", "unstructured": "Sagebiel RW, Parker F (1968) Cutaneous lesions of Fabry\u2019s disease: glycolipid lipidosis; light and electron microscopic findings. J Invest Dermatol 50:208\u2013213", "journal-title": "J Invest Dermatol"}, {"key": "15_CR37", "doi-asserted-by": "publisher", "first-page": "178", "DOI": "10.1007/s00401-005-0026-8", "volume": "111", "author": "C Navarro", "year": "2006", "unstructured": "Navarro C, Teijeira S, Dominguez C et al (2006) Fabry disease: an ultrastructural comparative study of skin in hemizygous and heterozygous patients. Acta Neuropathol 111:178\u2013185", "journal-title": "Acta Neuropathol"}, {"key": "15_CR38", "doi-asserted-by": "publisher", "first-page": "347", "DOI": "10.1212/WNL.32.4.347", "volume": "32", "author": "WJ Cable", "year": "1982", "unstructured": "Cable WJ, Dvorak AM, Osage JE, Kolodny EH (1982) Fabry disease: significance of ultrastructural localization of lipid inclusions in dermal nerves. Neurology 32:347\u2013353", "journal-title": "Neurology"}, {"key": "15_CR39", "author": "AM Dvorak", "first-page": "139", "year": "1981", "unstructured": "Dvorak AM, Cable WJL, Osage JE, Kolodny EH (1981) Diagnostic electron microscopy: II. Fabry\u2019s disease: use of biopsies from uninvolved skin: acute and chronic changes involving the microvasculature and small unmyelinated nerves. In: Summers SC, Rosen PP (eds) Pathology annual. Appleton-Century-Crofts, New York, pp 139\u2013158", "volume-title": "Pathology annual"}, {"key": "15_CR40", "doi-asserted-by": "publisher", "first-page": "1053", "DOI": "10.1136/jnnp.36.6.1053", "volume": "36", "author": "P Kahn", "year": "1973", "unstructured": "Kahn P (1973) Anderson-Fabry disease: a histopathological study of three cases with observations on the mechanism of production of pain. J Neurol Neurosurg Psychiatry 36:1053\u20131062", "journal-title": "J Neurol Neurosurg Psychiatry"}, {"key": "15_CR41", "doi-asserted-by": "publisher", "first-page": "109", "DOI": "10.1016/S0923-1811(98)00032-2", "volume": "18", "author": "LM Lao", "year": "1998", "unstructured": "Lao LM, Kumakiri M, Mima H et al (1998) The ultrastructural characteristics of eccrine sweat glands in a Fabry disease patient with hypohidrosis. J Dermatol Sci 18:109\u2013117", "journal-title": "J Dermatol Sci"}, {"key": "15_CR42", "doi-asserted-by": "publisher", "first-page": "221", "DOI": "10.1002/ana.410110302", "volume": "11", "author": "EH Kolodny", "year": "1982", "unstructured": "Kolodny EH, Cable WJ (1982) Inborn errors of metabolism. Ann Neurol 11:221\u2013232", "journal-title": "Ann Neurol"}, {"key": "15_CR43", "doi-asserted-by": "publisher", "first-page": "345", "DOI": "10.1007/BF00697017", "volume": "30", "author": "T Tabira", "year": "1974", "unstructured": "Tabira T, Goto I, Kuroiwa Y, Kikuchi M (1974) Neuropathological and biochemical studies in Fabry\u2019s disease. Acta Neuropathol 30:345\u2013354", "journal-title": "Acta Neuropathol"}, {"key": "15_CR44", "doi-asserted-by": "publisher", "first-page": "1315", "DOI": "10.1001/jama.286.11.1315", "volume": "286", "author": "M Mohrenschlager", "year": "2001", "unstructured": "Mohrenschlager M, Ring J, Abeck D (2001) Skin manifestations of Fabry disease. JAMA 286:1315", "journal-title": "JAMA"}, {"key": "15_CR45", "doi-asserted-by": "publisher", "first-page": "1295", "DOI": "10.1038/modpathol.3800634", "volume": "19", "author": "EG Fischer", "year": "2006", "unstructured": "Fischer EG, Moore MJ, Lager DJ (2006) Fabry disease: a morphologic study of 11 cases. Mod Pathol 19:1295\u20131301", "journal-title": "Mod Pathol"}, {"key": "15_CR46", "doi-asserted-by": "publisher", "first-page": "205", "DOI": "10.1007/s00431-005-0029-4", "volume": "165", "author": "AO Eggert", "year": "2006", "unstructured": "Eggert AO, Wossner R, Knoll A, Hamm H, Wanner C, Breunig FB (2006) Umbilical angiectases as the sole clinical sign of Fabry disease in a 9-year-old boy. Eur J Pediatr 165:205\u2013206", "journal-title": "Eur J Pediatr"}, {"key": "15_CR47", "doi-asserted-by": "publisher", "first-page": "185", "DOI": "10.1089/153968503768330229", "volume": "1", "author": "BR Amann-Vesti", "year": "2003", "unstructured": "Amann-Vesti BR, Gitzelmann G, Widmer U, Bosshard NU, Steinmann B, Koppensteiner R (2003) Severe lymphatic microangiopathy in Fabry disease. Lymphat Res Biol 1:185\u2013189", "journal-title": "Lymphat Res Biol"}, {"key": "15_CR48", "doi-asserted-by": "publisher", "first-page": "164", "DOI": "10.1002/(SICI)1096-9861(19970407)380:2<164::AID-CNE2>3.0.CO;2-1", "volume": "380", "author": "X Navarro", "year": "1997", "unstructured": "Navarro X, Verdu E, Wendelschafer-Crabb G, Kennedy WR (1997) Immunohistochemical study of skin reinnervation by regenerative axons. J Comp Neurol 380:164\u2013174", "journal-title": "J Comp Neurol"}, {"key": "15_CR49", "doi-asserted-by": "publisher", "first-page": "756", "DOI": "10.1002/mus.20062", "volume": "29", "author": "WR Kennedy", "year": "2004", "unstructured": "Kennedy WR (2004) Opportunities afforded by the study of unmyelinated nerves in skin and other organs. Muscle Nerve 29:756\u2013767", "journal-title": "Muscle Nerve"}, {"key": "15_CR50", "doi-asserted-by": "publisher", "first-page": "120", "DOI": "10.1001/archneur.1974.00490380068009", "volume": "31", "author": "A Onishi", "year": "1974", "unstructured": "Onishi A, Dyck PJ (1974) Loss of small peripheral sensory neurons in Fabry disease. Histologic and morphometric evaluation of cutaneous nerves, spinal ganglia, and posterior columns. Arch Neurol 31:120\u2013127", "journal-title": "Arch Neurol"}, {"key": "15_CR51", "doi-asserted-by": "publisher", "first-page": "1249", "DOI": "10.1212/WNL.52.6.1249", "volume": "52", "author": "LJ Scott", "year": "1999", "unstructured": "Scott LJ, Griffin JW, Luciano C et al (1999) Quantitative analysis of epidermal innervation in Fabry disease. Neurology 52:1249\u20131254", "journal-title": "Neurology"}, {"key": "15_CR52", "doi-asserted-by": "publisher", "first-page": "47", "DOI": "10.1002/ana.410440111", "volume": "44", "author": "NR Holland", "year": "1998", "unstructured": "Holland NR, Crawford TO, Hauer P, Cornblath DR, Griffin JW, McArthur JC (1998) Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases. Ann Neurol 44:47\u201359", "journal-title": "Ann Neurol"}, {"key": "15_CR53", "doi-asserted-by": "publisher", "first-page": "1042", "DOI": "10.1212/WNL.47.4.1042", "volume": "47", "author": "WR Kennedy", "year": "1996", "unstructured": "Kennedy WR, Wendelschafer-Crabb G, Johnson T (1996) Quantitation of epidermal nerves in diabetic neuropathy. Neurology 47:1042\u20131048", "journal-title": "Neurology"}, {"key": "15_CR54", "doi-asserted-by": "publisher", "first-page": "163", "DOI": "10.1055/s-2008-1040972", "volume": "16", "author": "WR Kennedy", "year": "1996", "unstructured": "Kennedy WR, Wendelschafer-Crabb G (1996) Utility of skin biopsy in diabetic neuropathy. Semin. Neurol 16:163\u2013171", "journal-title": "Semin. Neurol"}, {"key": "15_CR55", "doi-asserted-by": "publisher", "first-page": "2090", "DOI": "10.1093/brain/awh235", "volume": "127", "author": "MJ Hilz", "year": "2004", "unstructured": "Hilz MJ, Axelrod FB, Bickel A et al (2004) Assessing function and pathology in familial dysautonomia: assessment of temperature perception, sweating and cutaneous innervation. Brain 127:2090\u20132098", "journal-title": "Brain"}, {"key": "15_CR56", "doi-asserted-by": "publisher", "first-page": "115", "DOI": "10.1212/WNL.58.1.115", "volume": "58", "author": "M Polydefkis", "year": "2002", "unstructured": "Polydefkis M, Yiannoutsos CT, Cohen BA et al (2002) Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology 58:115\u2013119", "journal-title": "Neurology"}, {"issue": "59", "key": "15_CR57", "doi-asserted-by": "publisher", "first-page": "1094", "DOI": "10.1212/WNL.59.7.1094", "volume": "8", "author": "MC Chiang", "year": "2002", "unstructured": "Chiang MC, Lin YH, Pan CL, Tseng TJ, Lin WM, Hsieh ST (2002) Cutaneous innervation in chronic inflammatory demyelinating polyneuropathy. Neurology 8(59):1094\u20131098", "journal-title": "Neurology"}, {"key": "15_CR58", "doi-asserted-by": "publisher", "first-page": "361", "DOI": "10.1016/S0304-3959(99)00236-5", "volume": "84", "author": "MJ Hilz", "year": "2000", "unstructured": "Hilz MJ, Stemper B, Kolodny EH (2000) Lower limb cold exposure induces pain and prolonged small fiber dysfunction in Fabry patients. Pain 84:361\u2013365", "journal-title": "Pain"}, {"key": "15_CR59", "doi-asserted-by": "publisher", "first-page": "1634", "DOI": "10.1212/WNL.53.8.1634", "volume": "53", "author": "DN Herrmann", "year": "1999", "unstructured": "Herrmann DN, Griffin JW, Hauer P, Cornblath DR, McArthur JC (1999) Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology 53:1634\u20131640", "journal-title": "Neurology"}, {"key": "15_CR60", "doi-asserted-by": "publisher", "first-page": "867", "DOI": "10.1093/brain/114.2.867", "volume": "114", "author": "JG Llewelyn", "year": "1991", "unstructured": "Llewelyn JG, Gilbey SG, Thomas PK, King RH, Muddle JR, Watkins PJ (1991) Sural nerve morphometry in diabetic autonomic and painful sensory neuropathy. A clinicopathological study. Brain 114:867\u2013892", "journal-title": "Brain"}, {"key": "15_CR61", "doi-asserted-by": "publisher", "first-page": "1641", "DOI": "10.1212/WNL.53.8.1641", "volume": "53", "author": "MI Periquet", "year": "1999", "unstructured": "Periquet MI, Novak V, Collins MP et al (1999) Painful sensory neuropathy: prospective evaluation using skin biopsy. Neurology 53:1641\u20131647", "journal-title": "Neurology"}, {"key": "15_CR62", "doi-asserted-by": "publisher", "first-page": "373", "DOI": "10.1001/archneur.1963.00460100061007", "volume": "9", "author": "AN Rahman", "year": "1963", "unstructured": "Rahman AN, Lindenberg R (1963) The Neuropathology of Hereditary Dystopic Lipidosis. Arch Neurol 9:373\u2013385", "journal-title": "Arch Neurol"}, {"key": "15_CR63", "first-page": "377", "volume": "3", "author": "VW Steward", "year": "1968", "unstructured": "Steward VW, Hitchcock C (1968) Fabry\u2019s disease (angiokeratoma corporis diffusum). A report of 5 cases with pain in the extremities as the chief symptom. Pathol Eur 3:377\u2013388", "journal-title": "Pathol Eur"}, {"key": "15_CR64", "doi-asserted-by": "publisher", "first-page": "1513", "DOI": "10.1001/archneur.55.12.1513", "volume": "55", "author": "JC McArthur", "year": "1998", "unstructured": "McArthur JC, Stocks EA, Hauer P, Cornblath DR, Griffin JW (1998) Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol 55:1513\u20131520", "journal-title": "Arch Neurol"}, {"key": "15_CR65", "doi-asserted-by": "publisher", "first-page": "135", "DOI": "10.1016/S0304-3959(99)00007-X", "volume": "81", "author": "M Nolano", "year": "1999", "unstructured": "Nolano M, Simone DA, Wendelschafer-Crabb G, Johnson T, Hazen E, Kennedy WR (1999) Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation. Pain 81:135\u2013145", "journal-title": "Pain"}], "container-title": ["Fabry Disease"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-90-481-9033-1_15", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 17]], "date-time": "2019-03-17T15:17:15Z", "timestamp": 1552835835000}, "score": 18.038033, "issued": {"date-parts": [[2010]]}, "ISBN": ["9789048190324", "9789048190331"], "references-count": 65, "URL": "http://dx.doi.org/10.1007/978-90-481-9033-1_15", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T06:43:54Z", "timestamp": 1574750634992}, "reference-count": 0, "publisher": "West Indian Medical Journal", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["West Indian Med J"], "DOI": "10.7727/wimj.2016.574", "type": "journal-article", "created": {"date-parts": [[2017, 2, 21]], "date-time": "2017-02-21T14:23:59Z", "timestamp": 1487687039000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Cardiac Involvements of Fabry Disease"], "prefix": "10.7727", "author": [{"given": "S-M", "family": "Yuan", "sequence": "first", "affiliation": []}], "member": "4630", "published-online": {"date-parts": [[2017, 2, 21]]}, "container-title": ["West Indian Medical Journal"], "original-title": ["English"], "deposited": {"date-parts": [[2017, 2, 21]], "date-time": "2017-02-21T14:24:09Z", "timestamp": 1487687049000}, "score": 18.008352, "issued": {"date-parts": [[2017, 2, 21]]}, "references-count": 0, "URL": "http://dx.doi.org/10.7727/wimj.2016.574", "ISSN": ["0043-3144"], "issn-type": [{"value": "0043-3144", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T12:12:14Z", "timestamp": 1574511134086}, "reference-count": 0, "publisher": "BMJ", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Heart"], "published-print": {"date-parts": [[2013, 1, 15]]}, "DOI": "10.1136/heartjnl-2012-302407", "type": "journal-article", "created": {"date-parts": [[2012, 10, 20]], "date-time": "2012-10-20T03:39:03Z", "timestamp": 1350704343000}, "page": "69-70", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Steroids for Kawasaki disease: the devil is in the detail"], "prefix": "10.1136", "volume": "99", "author": [{"given": "M.", "family": "Levin", "sequence": "first", "affiliation": []}], "member": "239", "published-online": {"date-parts": [[2012, 10, 19]]}, "container-title": ["Heart"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1136/heartjnl-2012-302407", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T04:42:13Z", "timestamp": 1482468133000}, "score": 17.91234, "issued": {"date-parts": [[2012, 10, 19]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2012, 12, 23]]}, "published-print": {"date-parts": [[2013, 1, 15]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.1136/heartjnl-2012-302407", "ISSN": ["1355-6037"], "issn-type": [{"value": "1355-6037", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T17:19:09Z", "timestamp": 1574270349016}, "reference-count": 9, "publisher": "BMJ", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Archives of Disease in Childhood"], "published-print": {"date-parts": [[1990, 2, 1]]}, "DOI": "10.1136/adc.65.2.247-c", "type": "journal-article", "created": {"date-parts": [[2008, 12, 22]], "date-time": "2008-12-22T22:39:16Z", "timestamp": 1229985556000}, "page": "247-248", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Intravenous immunoglobulin in HIV infection."], "prefix": "10.1136", "volume": "65", "author": [{"given": "D", "family": "Gibb", "sequence": "first", "affiliation": []}, {"given": "M", "family": "Levin", "sequence": "additional", "affiliation": []}], "member": "239", "reference": [{"issue": "1", "key": "ref_1", "first-page": "146", "article-title": "Intravenous immunoglobulin in HIV infection: evidence for the efficacy of treatment", "volume": "64", "author": "Hague, R.A.; Yap, P.L.; Mok, J.Y.Q.", "year": "1989", "unstructured": "Hague RA, Yap PL, Mok JYQ, et al. Intravenous immunoglobulin in HIV infection: evidence for the efficacy of treatment. Arch Dis Child 1989;64:1 146-50.", "journal-title": "Arch Dis Child"}, {"key": "ref_2", "first-page": "162", "article-title": "The use of IV IgG in children with AIDS", "volume": "52", "author": "Oleske, J.M.; Connor, E.M.; Bohila, R.", "year": "1987", "unstructured": "Oleske JM, Connor EM, Bohila R, et al. The use of IV IgG in children with AIDS. Vox Sang 1987;52:162-75.", "journal-title": "Vox Sang"}, {"key": "ref_3", "doi-asserted-by": "crossref", "first-page": "300", "DOI": "10.1007/BF00442700", "article-title": "Intravenous immune globulin in symptomatic paediatric human immuno-deficiency virus infection", "volume": "147", "author": "Schaad, U.B.; Gianella-Borradori, A.; Perret, B.", "year": "1988", "unstructured": "Schaad UB, Gianella-Borradori A, Perret B, et al. Intravenous immune globulin in symptomatic paediatric human immuno-deficiency virus infection. Eur J Pediatr 1988;147:300-3.", "journal-title": "Eur J Pediatr"}, {"key": "ref_4", "first-page": "207", "article-title": "Intravenous gammaglobulin in infant acquired immunodeficiency syndrome", "volume": "5", "author": "Calvelli, T.A.; Rubinstein, A.", "year": "1986", "unstructured": "Calvelli TA, Rubinstein A. Intravenous gammaglobulin in infant acquired immunodeficiency syndrome. Peditar Infect Dis 1986;5:S207-10.", "journal-title": "Peditar Infect Dis"}, {"key": "ref_5", "first-page": "143", "article-title": "Restoration of suppressor T -cell functions in children with AIDS following intravenous gamma globulin treatment", "volume": "140", "author": "Gupta, A.; Novick, B.; Rubinstein, A.", "year": "1986", "unstructured": "Gupta A, Novick B, Rubinstein A. Restoration of suppressor T -cell functions in children with AIDS following intravenous gamma globulin treatment. Am J Dis Child 1986;140:143-6.", "journal-title": "Am J Dis Child"}, {"key": "ref_6", "first-page": "293", "article-title": "Human immunodeficiency virus infection in childhood, adolescence, and pregnancy: a status report and national research agenda", "volume": "83", "author": "Nicholas, S.W.; Sondheimer, D.L.; Willoughby, A.D.", "year": "1989", "unstructured": "Nicholas SW, Sondheimer DL, Willoughby AD, et al. Human immunodeficiency virus infection in childhood, adolescence, and pregnancy: a status report and national research agenda. Pediatnics 1989;83:293-308.", "journal-title": "Pediatnics"}, {"key": "ref_7", "first-page": "177", "article-title": "Compliance with an intravenous placebo in a randomised trial of intravenous immunoglobulin in HIV-infected children. Implications of AIDS for Mother and Child", "volume": "3", "year": "1989", "unstructured": "Riqau-Perez JG (for the IVIG Clinical Trial Study Group, NIH Bethesda, Maryland, USA). Compliance with an intravenous placebo in a randomised trial of intravenous immunoglobulin in HIV-infected children. Implications of AIDS for Mother and Child, Paris, Nov 1989. Abstract H3:177.", "journal-title": "Abstract"}, {"key": "ref_8", "doi-asserted-by": "crossref", "first-page": "1208", "DOI": "10.1136/adc.64.8.1208-a", "article-title": "Breath hydrogen excretion in infants with colic", "volume": "64", "author": "McKenzie, S.", "year": "1989", "unstructured": "McKenzie S. Breath hydrogen excretion in infants with colic. Arch Dis Child 1989;64: 1208.", "journal-title": "Arch Dis Child"}, {"key": "ref_9", "doi-asserted-by": "crossref", "first-page": "979", "DOI": "10.1016/S0022-3476(88)80567-5", "article-title": "Breath hydrogen response to milk containing lactose in colicky and noncolicky infants", "volume": "113", "author": "Moore, D.J.; Robb, T.A.; Davidson, G.P.", "year": "1988", "unstructured": "Moore DJ, Robb TA, Davidson GP. Breath hydrogen response to milk containing lactose in colicky and noncolicky infants. J Pediatr 1988;113:979-84.", "journal-title": "J Pediatr"}], "container-title": ["Archives of Disease in Childhood"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1136/adc.65.2.247-c", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 2]], "date-time": "2019-02-02T03:20:04Z", "timestamp": 1549077604000}, "score": 17.6452, "issued": {"date-parts": [[1990, 2, 1]]}, "references-count": 9, "journal-issue": {"published-print": {"date-parts": [[1990, 2, 1]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.1136/adc.65.2.247-c", "relation": {"cites": []}, "ISSN": ["0003-9888", "1468-2044"], "issn-type": [{"value": "0003-9888", "type": "print"}, {"value": "1468-2044", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T10:46:23Z", "timestamp": 1574246783686}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The Journal of Nervous and Mental Disease"], "published-print": {"date-parts": [[1935, 2]]}, "DOI": "10.1097/00005053-193502000-00005", "type": "journal-article", "created": {"date-parts": [[2006, 11, 22]], "date-time": "2006-11-22T18:19:47Z", "timestamp": 1164219587000}, "page": "176-191", "source": "Crossref", "is-referenced-by-count": 23, "title": ["THE NEUROLOGICAL ASPECTS OF UVEO-PAROTID FEVER"], "prefix": "10.1097", "volume": "81", "author": [{"given": "Paul M.", "family": "Levin", "sequence": "first", "affiliation": []}], "member": "276", "container-title": ["The Journal of Nervous and Mental Disease"], "language": "en", "link": [{"URL": "http://journals.lww.com/jonmd/Fulltext/10.1097/00005053-193502000-00005", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 11, 29]], "date-time": "2018-11-29T12:55:02Z", "timestamp": 1543496102000}, "score": 17.6452, "subtitle": [""], "issued": {"date-parts": [[1935, 2]]}, "references-count": 0, "journal-issue": {"issue": "2"}, "URL": "http://dx.doi.org/10.1097/00005053-193502000-00005", "ISSN": ["0022-3018"], "issn-type": [{"value": "0022-3018", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T07:35:31Z", "timestamp": 1574235331403}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The Journal of Nervous and Mental Disease"], "published-print": {"date-parts": [[1939, 3]]}, "DOI": "10.1097/00005053-193903000-00005", "type": "journal-article", "created": {"date-parts": [[2006, 10, 11]], "date-time": "2006-10-11T08:31:31Z", "timestamp": 1160555491000}, "page": "335-342", "source": "Crossref", "is-referenced-by-count": 3, "title": ["THE SYNDROME OF VESTIBULAR PARALYSIS IN MAN"], "prefix": "10.1097", "volume": "89", "author": [{"given": "PAUL M.", "family": "LEVIN", "sequence": "first", "affiliation": []}], "member": "276", "container-title": ["The Journal of Nervous and Mental Disease"], "language": "en", "deposited": {"date-parts": [[2018, 2, 9]], "date-time": "2018-02-09T06:14:53Z", "timestamp": 1518156893000}, "score": 17.6452, "subtitle": [""], "issued": {"date-parts": [[1939, 3]]}, "references-count": 0, "journal-issue": {"issue": "3"}, "URL": "http://dx.doi.org/10.1097/00005053-193903000-00005", "ISSN": ["0022-3018"], "issn-type": [{"value": "0022-3018", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T06:09:31Z", "timestamp": 1574230171651}, "publisher-location": "Chichester", "reference-count": 0, "publisher": "John Wiley & Sons, Ltd", "isbn-type": [{"value": "047001590X", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1038/npg.els.0002178", "type": "reference-entry", "created": {"date-parts": [[2006, 9, 20]], "date-time": "2006-09-20T12:15:22Z", "timestamp": 1158754522000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Neonatal Infectious Disease"], "prefix": "10.1002", "author": [{"given": "EGH", "family": "Lyall", "sequence": "first", "affiliation": []}, {"given": "M", "family": "Levin", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2001, 4, 19]]}, "container-title": ["Encyclopedia of Life Sciences"], "link": [{"URL": "https://onlinelibrary.wiley.com/doi/full/10.1038/npg.els.0002178", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 4]], "date-time": "2018-08-04T16:26:45Z", "timestamp": 1533400005000}, "score": 17.569305, "issued": {"date-parts": [[2001, 4, 19]]}, "ISBN": ["047001590X"], "references-count": 0, "URL": "http://dx.doi.org/10.1038/npg.els.0002178"}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}